J U N E 9 -1 2 E S G A R 2 0 1 5 P A R I S F R A N C E E u r o p e a n S o c ie t y o f G a s t r o in t e s t in a l a n d A b d o m in a l R a d io lo g y www.esgar.org www.esgar.org Quantification of these parameters was performed with own-developed software, selecting an ROI in the biopsied liver segment. Biopsy was used as gold standard for grading liver inflammation and fibrosis (ISHAK score). Steatosis (0-3) and iron deposits (0-4) were also registered. Results: For histological inflammation grading, patient's distribution was (grade/n): none/6; mild/56; moderate/13. Fibrosis grading distribution was: F0-F1/46; F2-F3/17; F4-F6/12. Also, 24 patients had liver steatosis while 36 had iron deposition. ADC values showed significant differences between grades of ISHAK necroinflammatory activity and fibrosis scores (p<0.05), with weak correlation with histological results. D* and f also showed significant differences (p<0.05) between ISHAK necroinflammatory grades. Only D values demonstrated significant differences between grades of steatosis or iron deposits. Conclusion: IVIM-DW-derived parameters may stage liver inflammation and fibrosis in diffuse liver disorders, even in the presence of steatosis or iron deposits.
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The role of diffusion-weighted MRI in assessment of inflammatory bowel disease C. Schmid-Tannwald 
Material and Methods: MR enteroclysis (MRE) examinations with DW-MRI
were reviewed from 24 patients with histologically proven Crohn's disease. Segments of bowel were evaluated for acute and chronic inflammation in three different reviews of the MRE images-T2w alone, T2w+DWI and T2+CET1w. Mean ADC values of normal bowel segments, as well as bowel segments with acute and chronic inflammation were calculated and compared. Results: 144 bowel segments in total were reviewed. Inflammation was present in 46 segments. Acute inflammation was present in 32 segments, chronic inflammation in 14. 98 bowel segments showed no inflammatory activity. Sensitivity for differentiation between normal and inflamed bowel segments was 0.6, 0.67 and 0.86 on T2w, T2w+DWI and T2+CET1w datasets, respectively. Sensitivity for differentiation between acute and chronically inflamed bowel segments was 0.85, 0.91 and 0.96, respectively. The mean ADC value of normal bowel (2.18 +/-0.37 x 10-3 mm²/s) was statistically significantly greater than the mean of inflamed bowel segments (p<0.001). The mean ADC value of acutely inflamed bowel segments was statistically significantly lower than that of chronically inflamed bowel segments (1.09+/-0.18 vs. 1.55 +/-0.21 x 10-3 mm²/s) (p<0.001). Conclusion: DW-MRI improves detection and differentiation of acute versus chronic inflammatory changes of the bowel in patients with Crohn's disease compared to T2w-images alone.
SS 2.05
MRI as a potential "one-stop-shop" staging tool for colon cancer: can it replace CT for local staging? M.J. 
Eindhoven/NL
Purpose: CT is routinely used for staging of colon cancer. In the revised Dutch guidelines, MRI is recommended for liver staging because of its superiority to CT. If MRI proves valuable to also stage the local tumor, it could be used as a 'one-stop-shop' tool with the added benefit of avoiding radiation and nephrotoxic contrasts. Aim of this prospective study was to evaluate the performance of MRI for local staging of colon cancer.
Material and Methods:
In an ongoing pilot study, we included 26 patients with colon cancer, undergoing MRI (1.5T) including T2TSE, BTFE and DWI sequences of the whole abdomen. Two experienced readers independently evaluated the examinations and scored; tumor location, T-stage (T1-2 vs. T3-4), nearby fascia/serosal involvement and N-stage (N0/N+). Histopathology was the reference standard.
Results: Histology found 18/26 T3-4 tumors, 6/26 fascia involvement and 9/26 N+ tumors. Both readers correctly identified all tumors with MRI. For assessment of T-stage, fascia involvement and N-stage, Reader 1 had a sensitivity/ specificity of 93%/64%, 100%/79% and 67%/82%. For Reader 2, results were 88%/66%, 83%/75% and 64%/86%. Interobserver agreement was moderate to almost perfect (κ0. 43, 0.44 and 0.84) . Conclusion: Our pilot data suggest that MRI has a high sensitivity for detecting colon tumors and most important prognostic factors. MRI may thus replace CT in staging colon cancer. If the FOXTROT trial will prove that neoadjuvant chemotherapy for locally advanced colon tumor will affect outcome, MRI has potential to accurately identify high-risk patients.
SS 2.06
withdrawn Ga]-DOTATOC (n=9). For small bowel distension, a contrast solution (1500cc of mannitol and locust bean gum) was ingested. The following sequences were acquired: a) coronal TrueFISP; b) coronal T2w HASTE with fat saturation; c) coronal T1w 3D VIBE pre-and post-gadolinium; d) axial and coronal T1w 2D FLASH post-gadolinium. Datasets were reviewed with regard to co-registration of anatomical structures based on a 3-point scale (3: good co-registration, 2: slight misregistration, 1: significant misregistration) and image quality using a 4-point scale (1: non-diagnostic -4: excellent quality). Furthermore, visualization of intestinal and extraintestinal pathologies was described. Results: PET/MR enterography was well tolerated by all patients. High overall image quality was achieved (mean score MRI: 3.2, PET: 2. 3) with good co-registration of ). PET/MR enterography allowed for an excellent visualization of intestinal pathologies including inflammatory and tumor manifestations. Furthermore, lymph node metastases were depicted in two patients. Conclusion: PET/MR enterography is technically feasible and offers good coregistration of bowel structures. This new method enables a multimodal assessment of bowel lesions in malignant and inflammatory disease.
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SS 3.01
Is there a connection between mesenteric panniculitis and lymphoma? V. Khasminsky, E. Atar, G. Bachar; Petah Tikva/IL Purpose: Mesenteric panniculitis has long been associated with malignancy and lymphomas especially. Our aim was to elucidate the connection between mesenteric panniculitis and malignancy by establishing its prevalence among patients with known diagnosis of lymphoma and comparing it to the prevalence in general population and in a matched control group.
Material and Methods:
We retrospectively evaluated CT and PET-CT examinations of 166 patients with established diagnosis of non-Hodgkin lymphoma. Mesenteric panniculitis was identified on the basis of five CT imaging signs described in literature. To distinguish mesenteric panniculitis from the involvement of mesentery by lymphoma, we relied on PET-CT evidence of FDG uptake in the mesenterium. For each lymphoma patient, we also chose two control subjects matched for age, gender and examination time period, for a total of 330 subjects. Results: Mesenteric panniculitis was identified in 3 patients out of 166 in the lymphoma group (prevalence 1.8%) and in 7 patients out of 330 in the control group (prevalence 2.1%). None of the patients from the control group developed malignancy during the follow-up of 24 to 60 months.
Conclusion:
The prevalence of mesenteric panniculitis among patients with NHL was similar to its prevalence in the control group and in general population. This runs contrary to the proposition that mesenteric panniculitis is associated with lymphomas. This obviates the need to recommend searching for malignancy in case of incidental discovery of mesenteric panniculitis.
SS 3.02
In vivo study of microcirculation in a murine model of pseudomyxoma peritonei using the intravoxel incoherent motion method for the assessment of antiangiogenic drugs A. Dohan 
Dijon/FR
Purpose: Pseudomyxoma peritonei (PMP) is characterized by mucinous ascites confined to the peritoneal cavity. The aim of this study was to monitor an antiangiogenic treatment in a murine model with the intravoxel incoherent motion (IVIM)-derived parameters obtained by MRI at 1.5T. Material and Methods: Twenty nude mice orthotopically xenografted with human PMP had T2-spin echo MRI 8 weeks after the graft. All mice underwent diffusion-weighted images with 13 b values to fit the IVIM-derived parameters, namely, the pure-diffusion coefficient and the perfusion-related diffusion fraction and coefficient. Fitting was obtained using an automated MATLAB script. Ten mice were treated with Sorafenib (60mg/kg/j), and ten untreated mice were used as controls. MRI acquisitions were repeated 1 week and 4 weeks after the beginning of the treatment. Then, mice were killed and tumor angiogenesis was quantified with blood analysis and histological markers. Results: The pure-diffusion coefficient and the perfusion fraction were not different between the 2 groups at the different times (p<0.05). Perfusion-related diffusion coefficient decreased at the first week in the treated group (p=0.5) and became significantly lower at the fourth week (p<0.05). It remained stable in the control group. Histological markers confirmed a greater vessel density in the tumor compared to treated group (p<0.05). Serum levels of VEGF, PlGF, and TGF-β were lower in the treated group (p<0.01). Conclusion: IVIM parameters are useful to monitor the effect of an antiangiogenic drug in a murine model of PMP.
SS 3.03
Diagnosis of pseudomyxoma peritonei with MR imaging A. Dohan 
Seoul/KR
Purpose: To assess the advantages of additional multiplanar sliding-slab averaging (SSA) review of 2-mm-thick (thin) sections over stack review of 5-mmthick (thick) sections in inconclusive 2-mSv CT cases in adolescents and young adults with suspected appendicitis. Material and Methods: IRB approved this retrospective study and waived informed consent requirement. We included 149 patients (mean age, 28.0 years; 61 males; 88 females) in whom original CT reports were inconclusive for diagnosis of appendicitis. Five radiologists independently reviewed the thick sections in stack mode and then the thin sections using SSA. In each review, they rated the likelihood of appendicitis and the appendix visualization in 5-and 3-point Likert scales, respectively. Diagnostic performance and confidence were compared between two reviews using receiver operating characteristic (ROC) analysis, McNemar tests, and Wilcoxon signed rank tests. Results: The pooled area under the ROC curve (AUC) was 0.90 and 0.93 for stack and SSA reviews, respectively, (90% CI for difference, [0.002, 0.06], P = 0.087). The differences were not always statistically significant, but SSA review tended to increase individual readers' AUC (range, 0.86-0.93 vs. 0.87-0.97, stack vs. SSA review); improve confidence in diagnosing (mean score, 3.6-4.7 vs. 3.9-4.7) or ruling out (1.6-2.1 vs. 1.5-1.9) appendicitis; reduce indeterminate interpretations (0%-15% vs. 0%-11%); and enhance normal appendix visualization (1.1-1.7 vs. 1.1-1.9). Conclusion: Additional SSA review of thin sections tends to improve diagnostic performance and confidence when conventional stack review of thick sections is inconclusive.
SS 3.07
Periportal edema caused by acute appendicitis I.A. Tamir, O. Benjaminov, E. Atar, G. Bachar; Petah Tikva/IL Purpose: Periportal edema is a possible sequel of a wide range of diseases. Although non-specific, the identification of periportal edema by MDCT examination brings the radiologist for a thorough quest after the possible cause. All the relevant pivotal textbooks and atlases give a long differential diagnosis list of all the possible causes of periportal edema. Acute appendicitis is not included as a possible cause of periportal edema.
Material and Methods:
The aim of this study is to determine the interrelated connection between periportal edema and acute appendicitis. We consecutively and chronologically studied 181 patients, from 19 to 92 years old, between January 2010 and August 2013, who were diagnosed with acute appendicitis. All the studies were evaluated by 2 senior radiologists who approved the imagistic diagnosis of appendicitis with the presence or absence of periportal edema. Results: Periportal edema was identified in 29 patients of 181 studied (16 %). Although the difference was statistically non-significant, the mean age of periportal edematous group stood on 42±18 compared with the control group 48±16 (P=0.298). We additionally found increased frequency with complicated cases as gangrenous appendicitis (n=13), periappendicular abscess (n=5) and peritonitis (n=2). Conclusion: Periportal edema is a possible sequel of acute appendicitis, especially with its complicated forms or with the younger adult population. Acute appendicitis should be included in the differential diagnosis as a possible cause of periportal edema.
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Assessment of imaging criteria to predict stage III colon cancer using multidetector computed tomography E. Rollvén, L. Blomqvist, M. Abraham Nordling, T. Holm; Stockholm/SE Purpose: To study different imaging criteria for prediction of stage III disease in colon cancer using multidetector computed tomography (MDCT). Material and Methods: From 483 consecutive patients who underwent elective primary resection during 2008-2011, a cohort of 119 patients who had performed preoperative MDCT was identified. MDCT's were reviewed with assessment of the number of lymph nodes, their anatomical distribution, size, size ratio, internal heterogeneity, presence of irregular outer border and contrast enhancement. Sensitivity, specificity, PPV and NPV for each studied image criteria for prediction of stage III disease were calculated. Results: Of 119 patients, 80 were stage I-II and 39 were stage III. Of the studied criteria, internal heterogeneity in at least one lymph node resulted in the best performance with a sensitivity and specificity of 79 and 84%. Presence of irregular outer border resulted in a sensitivity and specificity of 59 and 81%. If both internal heterogeneity and/or irregular outer border was used as a criterion, this resulted in a sensitivity and specificity of 85% and 75%. None of the size criteria used was predictive for stage III disease. Conclusion: When performing preoperative MDCT in patients with colon cancer, the imaging criteria that allow best prediction of stage III disease are either presence of at least one lymph node with internal heterogeneity or internal heterogeneity and/or irregular outer border. These criteria have to be validated in a prospective study.
SS 3.10
Paraduodenal hernia: clinical and imaging findings in 5 patients with emphasis on multi-detector CT findings I.Y. Kim, Y.T. Kim, H.C. Shin; Cheonan/KR Purpose: To review the clinical and radiologic features of paraduodenal hernia and to derive useful radiographic and multi-detector CT (MDCT) findings to assist in diagnosis. Material and Methods: Retrospective review of medical records revealed 5 patients with surgically proven paraduodenal hernia (from September 2006 to September 2011) who had 5 MDCT scans and one small-bowel follow-through (SBFT) images and all abdominal plain film. Two radiologists reviewed those images with consensus and classified as right paraduodenal hernia and left paraduodenal hernia. Results: There were 3 cases of left paraduodenal hernia and 2 cases of right paraduodenal hernia. Male and female sex ratio was 4:1. Mean age is 52.2 (age range 30-71). CT signs common to both types of paraduodenal hernia included evidence of small-bowel obstruction; clustering of small bowel; stretched, displaced, crowed, and engorged mesenteric vessels; and displacement of other bowel segments. Left-sided paraduodenal hernias demonstrated a saclike mass of small-bowel loops interposed between the stomach and pancreatic tail. All paraduodenal hernias were diagnosed confidently at retrospective review of CT and SBFT findings. Abdomen plain film suggestively diagnosed at retrospective review of paraduodenal hernia with 60% of accuracy. Conclusion: Paraduodenal hernias are an important and underdiagnosed condition. Left-sided paraduodenal hernias are more common and accurate diagnosis is important for proper treatment. MDCT may allow confident diagnosis in all patients; however, abdomen plain film and SBFT have its role in the diagnosis. 
SS 4.02
Prediction of therapeutic response after FOLFOX and FOLFIRI treatment in patients with liver metastasis from colorectal cancer using computerized CT texture analysis S.J. Ahn, J.H. Kim, S.J. Park, J.K. Han, B.I. Choi; Seoul/KR Purpose: To determine whether the pretreatment CT texture analysis of hepatic metastasis from colorectal cancer is predictive of response after cytotoxic chemotherapy. Material and Methods: The study included 145 patients with liver metastasis from colorectal cancer who underwent CT scan before and after forth cycles of cytotoxic chemotherapy using FOLFOX and FOLFIRI. Computerized CT texture of hepatic metastasis was quantified using pretreatment CT in both 2D and 3D analysis. We analyzed an independent predictor for response using multivariate logistic regression analysis. We also compared texture analysis between each CT machines. Response evaluation based on RECIST criteria. For statistical analysis, t-test and Kruskal-Wallis test was applied. Results: 55 responding and 90 non-responding patients were evaluated. Responding groups had a significantly different mean attenuation, skewness, homogeneity, percentile CT attenuation, GLCM moments in 2D analysis and mean attenuation, standard deviation, entropy, homogeneity, percentile CT attenuation, GLCM moments in 3D analysis (P<0.05). Skewness (odds ratio, 6.739) in 2D, mean attenuation (odds ratio, 2.587), standard deviation (odds ratio, 3.163) in 3D were independent predictors for therapeutic response (P<0 .05). However, only skewness (p=0.213) in 2D showed no significant different between each CT machines. Conclusion: CT texture analysis using pretreatment CT is useful for prediction of therapeutic response evaluation after cytotoxic chemotherapy in patients with liver metastasis from colorectal cancer. Skewness in 2D was an independent predictor regardless of CT machines.
Scientific Sessions
Authors' index SCIENTIFIC SESSIONS / WEDNESDAY, JUNE 10, 2015 
Rotterdam/NL
Purpose: Previous research showed promise for whole-liver CT-texture analysis to discriminate between colorectal cancer (CRC) patients with/without synchronous hepatic metastases. The aim of this multicenter study was to validate these findings and investigate whether CT texture can also predict the development of metachronous metastases before they become visible on CT.
Material and Methods: 180 patients were included, of which a preliminary analysis of n = 67 was performed at the time of writing. Three subgroups were assessed: patients [A] without metastases (n = 27), [B] patients who developed metachronous metastases within 24 months (n = 20) and [C] those with synchronous metastases (n = 20). Wholeliver texture analysis was performed on primary staging portal-phase CT by manual delineation of the non-diseased liver. Mean greylevel intensity (M), entropy (E) and uniformity (U) were derived with different filter values (unfiltered = 0.0, fine = 0.5, medium = 1.5, coarse = 2.5). Univariate logistic regression analysis was performed to identify potentially predictive parameters, which were further evaluated by ROC-curve analysis. Results: To differentiate between group A/C, all texture parameters (except E 0.0 ) showed potential predictive value with AUCs to diagnose synchronous metastasis ranging between 0.60 and 0.92 (for U 1.5 ). To differentiate between group A/B, E 0.5 and M 1.5 were predictive with AUCs of 0.63 and 0.62 to diagnose patients who will develop metachronous metastases. Conclusion: Whole-liver CT texture analysis can differentiate between patients with/without metastatic disease and may also hold promise to diagnose patients with occult metastases who will develop metachronous disease.
SS 4.06
Comparison of Tumor Response by Response Evaluation Criteria in Solid Tumors (RECIST) and Choi criteria in patients treated with yttrium-90 radioembolization for intrahepatic cholangiocarcinoma L. Beuzit, V. Brun, E. Garin, E. Boucher, K. Boudjema, J. Edeline, Y. Rolland; Rennes/FR Purpose: To determine whether the application of Choi criteria to patients with intrahepatic cholangiocarcinoma (ICC) treated by yttrium90 radioembolization improves prognosis classification compared with Response Evaluation Criteria in Solid Tumors (RECIST). Material and Methods: The authors retrospectively analyzed 45 patients with locally advanced ICC treated with yttrium90 glass microspheres. Patients must have undergone contrast-enhanced computed tomography before and after treatment. CT scans were analyzed using RECIST 1.1 and the criteria described by Choi in stromal gastro-intestinal tumors. Results: The rates of objective response (OR), stable disease (SD), and progressive disease (PD) were 11%, 76%, and 13%, respectively, according to RECIST and 82%, 4%, and 13%, respectively, according to Choi criteria. Patients who achieved an OR according to Choi criteria had a longer overall survival (OS) than non-responding patients with SD or PD (median 19.9 months and 5.4 months, respectively (p = .003)), whereas there was no significant difference in the survival of responding and non-responding patients according to RECIST (p = .387). In the 40 non-responding patients according to RECIST, response according to Choi distinguished a significantly different prognosis, with a median overall survival of 19.9 months and 5.4 months in patients who were responding (n = 32) and non-responding (n = 8), respectively (p = .005). Conclusion: Choi criteria better assessed the prognosis of patients who received yttrium90 microsphere radioembolization for ICC than RECIST.
SS 4.07 withdrawn by the authors
SS 4.08
Diffusion-weighted MRI at 3T: the optimal maximum b value for differential diagnosis of focal solid liver lesions K. Lomovtseva, G.G. Karmazanovsky, N. Karel'Skaya, V.A. Vishnevsky; Moscow/RU Purpose: To compare three different b values (600, 800 and 1000 s/mm 2 ) for differentiation between benign and malignant focal solid liver lesions and determine the optimal b value. Material and Methods: 26 patients with 46 focal solid liver lesions (24 metastases, 5 hepatocellular carcinomas, 10 cholangiocarcinomas, 6 focal nodular hyperplasias, 1 hepatocellular adenoma) underwent respiratory-triggered DWI MRI (3T), using b values 0, 600, 800 and 1000 s/mm 2 . Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of each lesion for b = 600, 800 and 1000 s/mm 2 were calculated. Apparent diffusion coefficients (ADC) of lesion were measured on ADC maps, which were automatically created for the following b values: 0-600, 0-800 and 0-1000 s/mm 2 . The ROC analysis was performed and cutoff values of ADC of lesion for differentiation of benign and malignant lesions for every maximum b value were determined. Results: The mean ADC values of benign solid lesions were significantly higher than malignant solid lesions at all b values of 600, 800 and 1000 s/mm 2 (p < 0.001). The largest area under the ROC curve was reached by ADC lesion 600 (0.859 Purpose: To investigate if superb microvascular imaging (SMI) technology, recently developed to visualize extremely low-velocity flows with high frame rate and high resolution without contrast agents, is helpful for the diagnosis of hepatic tumors. Material and Methods: Forty hepatic tumors of 28 patients were enrolled in our study. The tumors consisted of hemangiomas (n = 15), focal nodular hyperplasia (FNH) (n = 7), hepatocellular carcinomas (n = 7), and metastasis (n = 11). All lesions were pathologically or radiologically confirmed. Mean tumor was 1.9 cm in diameter (range, 0.9 cm to 5.0 cm). Using SMI technology, all lesions were scanned and categorized into subgroups according to the flow pattern on SMI. Results: Hemangiomas showed nodular rim pattern in 33% and dot-like pattern in 20%, all of which were very specific findings for the diagnosis of hemangiomas. FNH showed spoke wheel pattern in 43% and radiating vessel pattern in 29%, which were very specific findings for the diagnosis of FNH. Other tumors did not show any specific pattern on SMI. Conclusion: SMI is a very promising technology for the depiction of very slow flow within hepatic tumors, which may give an additional clue to differentiate hepatic tumors on non-enhanced ultrasound.
SS 4.10
Best diagnostic clue for the diagnosis of biliary hamartomas (von Meyenburg complex) 
Material and Methods:
We retrospectively reviewed MR findings of 37 AIP and 42 PC lesions that were analysed with 3-T MRI including dynamic contrast-enhanced MRI (DCE-MRI). All AIP lesions were diagnosed based on the International Consensus Diagnostic Criteria for autoimmune pancreatitis. All PC lesions were pathologically diagnosed by surgical resection or biopsy. Sensitivity, specificity and accuracy were calculated. In addition, frequencies of MR findings were compared between AIP and PC using Fisher's exact test. Results: Sensitivity/specificity/accuracy of MR findings such as 1) speckled hyperintensity on fat-suppressed T1-weighted image (FS-T1WI), 2) speckled enhancement on pancreatic phase DCE-MRI, 3) capsule-like rim, 4) homogeneous delayed enhancement, 5) duct-penetrating sign, 6) enhanced duct sign, 7) no main pancreatic duct (MPD) upstream dilatation were as follows in the same order: 1) 100/97.6/98.7%, 2) 97.3/97.6/97.5%, 3) 35.1/100/69.6%, 4) 94.6/85.7/89.9%, 5) 73.0/100/87.3%, 6) 13.5/100/59.5%, 7) 100/64.3/81.0%. Sensitivity, specificity and accuracy of speckled hyperintensity on FS-T1WI and speckled enhancement on pancreatic phase DCE-MEI was over 95%. All findings except for enhanced duct sign was more frequently seen in AIP than in PC (P < 0.0001). Conclusion: Speckled hyperintensity on FS-T1WI and speckled enhancement on pancreatic phase DCE-MRI were most useful in differentiating between AIP and PC at 3-T MRI.
SS 5.08
Magnetic resonance imaging volumetry of the pancreas in autoimmune pancreatitis: evaluation of pancreas volume at diagnosis, post-therapy and follow-up N. Cardobi Results: Between patients with benign condition and those with cancer, there were no statistically significant differences for the presence of solid lesions, site of stenosis and length of MPD stricture (p > 0,1). Cancer caused a higher prevalence of complete stenosis (100% versus 48,6%; p = 0,037), upstream dilated side branches (100% versus 51,4%; p = 0.049) and a considerable lower prevalence of positive duct-penetrating sign (0% versus 88,6%; p < 0.001). The number of stenoses was higher in the presence of benign conditions (1,23 versus 1,00; p < 0,01). Upstream MPD diameter was higher in cancer-induced stenoses compared with non-neoplastic strictures, both in basal conditions (average 3,96 mm versus 2,47 mm; p < 0,01) and after secretin administration (average 4,51 mm versus 2,94 mm; p < 0,001). Conclusion: Secretin-enhanced MRCP is a useful technique to evaluate MPD stenosis; the presence of a single complete stenosis with upstream dilated side branches and increased MPD caliber, without stenosis resolution after secretin administration, is highly suggestive of malignancy.
SS 5.10
The morphologic evolution of necrotic pancreatic zones in acute pancreatitis: is there a reversible pattern? 
Moscow/RU
Purpose: Necrotizing pancreatitis is a severe form of acute pancreatitis characterized by destruction of pancreatic parenchyma, peripancreatic tissues or both. The accepted CT criteria for diagnosis of pancreatic necrosis are defined as focal or diffuse zones of non-enhanced parenchyma or areas with highly decreased attenuation depicted on the images with contrast administration. The aim was to find whether areas with decreased attenuation in pancreatic parenchyma always correspond to pancreatic necrosis or could be reversible in the setting of acute pancreatitis. Material and Methods: 25 patients with contrast-enhanced initial and followup CT scans were included in the study. Two independent observers analyzed both CT scans retrospectively. The size and change in CT density of hypodense parenchymal areas and other related findings were precisely evaluated on primary and follow-up CT-scans. Results: In 28% of patients with acute necrotizing pancreatitis, hypodense parenchymal areas on initial CT scan showed increase in HU values in follow-up CT studies. Patients were divided into two groups: those with increased HU values in follow-up studies (Group 1) and those who did not (Group 2). There were statistically significant differences between Group 1 and Group 2 in the size of the primary area and in HU-delta (by size: t-test -p = 0,006, Mann-Whitney U test -p=0,01; by HU-delta: t-test -p = 0,00, Mann-Whitney U test -p = 0,00).
Conclusion:
Our results suggest that small hypodense zones in pancreatic parenchyma may not always represent areas of pancreatic necrosis. Reversible pancreatic ischemia and/or decreased perfusion of parenchyma could be considered in cases with small hypodense areas in acute pancreatitis. Villejuif/FR Purpose: To assess computed tomography (CT) modifications after neoadjuvant FOLFIRINOX chemotherapy for borderline (BR) and locally advanced (LA) pancreatic adenocarcinoma (PAC). Material and Methods: Thirty-six patients with BR and LA PAC who received neoadjuvant FOLFIRINOX chemotherapy and had undergone surgery were retrospectively included. Baseline CT and pre-surgical CT were reviewed by two observers. Largest diameter, product of the 3 diameters (P3D), arterial (superior mesenteric/coeliac/hepatic arteries) and venous (superior mesenteric/portal veins) involvement (score=0-5) and NCCN classification were studied and compared to pathological data. Results: There were significant decreases of the largest diameter and of P3D (p<0.0001) and a partial response (PR) according to RECIST was found in 17/36 patients (47%). The largest diameter and P3D variations were significantly higher in patients with pathological response (T0-1N0) (p<0.05). A decrease of the arterial or venous involvement was respectively found in 9 (25%) and 8 patients (22%). In the opposite, progression of the vascular involvement was seen in 2 (5%) patients associated with a shorter disease-free survival after the surgery (p<0.05). 31 patients had R0 resection and among them only 4 (13%) exhibited a downstaging according to NCCN classification, while 27 (87%) did not. Conclusion: Despite a lack of NCCN downstaging during chemotherapy most of BR and LA patients were R0 at surgery suggesting that additional imaging pattern must be found to accurately predict post-chemotherapy resectability.
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Authors' index SCIENTIFIC SESSIONS / THURSDAY, JUNE 11, 2015 Purpose: To compare a high tube voltage, normal-iodine load (standard) protocol multidetector CT (MDCT) with a low tube voltage, normal-or high-iodine load protocol in patients with pancreatic cancer regarding image quality, tumor conspicuity and vessel involvement. Material and Methods: In this IRB-approved prospective study, thirty consecutive patients (14 men, mean age 66 years) underwent, preoperatively twice, multiphase 64-channel MDCT examinations according to: (i) standard protocol (SP; 120 kV, 0.75 gI/Kg body weight) and (ii) protocol A (PA; 80 kV, 0.75 gI/kg) or B (PB; 80 kV, 1 gI/kg). In all examinations, two independent readers evaluated blindly the image quality, tumor conspicuity and vessel involvement. A third reader measured the pancreas-to-tumor contrast-to-noise ratio (CNR) in the pancreatic parenchymal (PPP) and portal-venous (PVP) phases. Statistical analysis was performed with Chi-square test. Results: There was no significant difference between protocols in image quality (p=0.12). Tumor conspicuity was significantly higher in PA and PB compared to PS (both, p<0.05). Vessel involvement between PA and PS coincided in 93% of patients, whereas in only 81% between PB and PS. CNR in PPP was significantly higher in PB compared to PA and SP (both, p<0.05) and in PVP significantly higher in PB compared to SP (p<0.0001). Conclusion: A low tube voltage and high-iodine load protocol improves tumor conspicuity in patients with pancreatic cancer compared to standard protocol MDCT; however, there might be slight discrepancy between them in assessing vessel involvement.
SS 6.04
Pancreatic metastases from renal neoplasms and neuroendocrine pancreatic tumors: differential diagnoses
Purpose: Pancreatic metastases from renal-cell carcinoma (PRCC) and neuroendocrine pancreatic tumors (PNET) are both hypervascular and the differential diagnosis can be difficult. The purpose of this study is to compare the multiphasic MDCT features of these two lesions.
Material and Methods:
We retrospectively compared the MDCTs performed on 28 patients with history of clear-cell carcinoma and PRCC with 28 patients with PNET, matched by size. All patients underwent multiphasic CT. In patients with multiple PRCCs, the largest lesion was analyzed. One reader evaluated the site, margins, enhancement intensity and homogeneity (subjective comparison to normal parenchyma) in the arterial and venous phases, vascular invasion and main pancreatic duct (MPD) dilatation. Results: No significant difference was observed in lesion distribution. All lesions had well-defined margins in both populations. In the arterial phase, 26/28 PRCC and 24/28 PNET were hypervascular, while in the venous phase 17/28 PRCC and 17/28 PNET were hyperattenuating; enhancement was homogeneous in 14/28 PRCC and in 17/28 PNET (all: p = n.s.). Homogeneous PNETs were significantly smaller than inhomogeneous ones (21 ± 4.2 mm vs. 43.18 ± 6.92 mm, p = 0.0073). Vessel invasion was noted in 3/28 PRCC and 6/28 PNET. MPD was dilated in 5/28 cases in both populations. Conclusion: Both RCC and PNET are well-defined, hypervascular lesions, usually without MPD dilatation or vessel infiltration. We did not find CT features helpful for a differential diagnosis. The best diagnostic clue for PRCC is a history of renal cell carcinoma.
SS 6.05
Pancreatic endocrine tumors (PETs): multimodality imaging features with histopathological correlation In-octreotide: n = 12; US: n = 5) of 33 patients (21 female; mean age 55 years) with resected PETs was evaluated for tumor location, size, morphology, echogenicity/attenuation/signal intensity,
111
In-octreotide uptake, cystic degeneration, and late arterial phase enhancement. Tissue specimens were assessed for stromal fibrosis, vascular density, and presence of capsule. Correlation between imaging and histopathology was made using the FisherFreeman-Halton test.
Results: PET arose from the pancreatic head/neck (n = 13), body (n = 8), and tail (n = 12). On CT, PET appeared solid (74%), well defined (92.6%), and oval shaped (51.9%). On contrast-enhanced CT, PET appeared hypervascular in 50%. Septations (25.9%) and calcifications (18.5%) were uncommon. On MRI, PET appeared solid (60%), encapsulated (66.6%), oval (75%), hyperintense on T2-WI (75%), and predominantly hypo-or isoenhancing (69%). Cystic PETs (3.0 cm) were not significantly larger than solid (2.3 cm) PETs (CT, p = 0.608; MRI, p = 0.441).
In-octreotide uptake was demonstrated in 66.6% of cases. By US, PET appeared hypoechoic (60%). By histopathology, PETs were encapsulated (65%); stromal fibrosis comprised <33% of the tumor (71%) with average vascular density (48%). The degree of fibrosis and hypointensity on T2-WI were significantly associated (p = 0.004). Conclusion: PETs are most commonly oval-shaped, solid, and well-defined/ encapsulated masses. Low signal intensity on T2-WI correlates with extensive intratumoral fibrosis. Approximately, 50% of PETs are not hyperenhancing on contrast-enhanced CT/MRI. Peschiera del Garda/IT Purpose: To assess the diagnostic value of diffusion-weighted imaging (DWI) to evaluate pancreatic neuroendocrine tumors (PNETs) regarding identification, characterization, and staging. Material and Methods: The MR findings of 30 consecutive patients with surgically resected pancreatic neuroendocrine tumors (PNETs) were retrospectively compared to those of 30 consecutive patients with pancreatic ductal adenocarcinomas (PDACs). T1-and T2-weighted, arterial, portal and delayed phase, b800 and ADC map images were evaluated by two readers in consensus, who performed a quantitative and a qualitative analysis. The latter was completed by a confidence assessment for PNET diagnosis and liver metastases diagnosis by two separate blinded readers. Results: PDACs had statistically significantly higher mean ADC value compared to PNETs (1.40 vs. 1.19 x 10 -3 mm 2 /s; p = 0.001). b800 images provided the highest lesion conspicuity (p <0.05). On blinded readers' analysis, DWI did not provide significant advantages over other sequences for PNET diagnosis. Regarding liver metastases diagnosis, substantial agreement between readers for DWI and an overall lower diagnostic confidence for conventional sequences vs. DWI were found (both p <0.001). DWI had high AUC values for both readers (0.879 and 0.824) regarding liver metastases diagnosis. Conclusion: DWI may be of value for the identification of PNETs and for the detection of liver metastases, while it does not seem to provide significant improvements regarding diagnosis. Nevertheless, ADC quantification may be helpful for differential diagnosis. Y-DOTATOC treatment (full treatment: 4 cycles at 1.85 GBq/m²/cycle; 8 weeks between cycles). Responses at 7 weeks were assessed with ADC ratio7w at WB-DWI and Response Evaluation Criteria in Solid Tumors (RECIST) at contrast-enhanced magnetic resonance imaging (MRI) Kaplan-Meier and log-rank tests were used to correlate the response variables with progression-free (PFS) and overall survival (OS). Results: Median PFS was 9 months and median OS 17 months. Survival analyses showed significant effects on PFS by the number of therapy cycles (p=0.026), tumour grade (p=0.024) and ADC ratio7w (p<0.0001) and significant effects on OS by the number of therapy cycles (p=0.006), tumour grade (p=0.0047), nuclear antigen KI67 index (p=0.013) and ADC ratio7w (p<0.0001). After multivariable analysis, the ADC ratio7w remained the only significant predictor of 9 months PFS (p=0.011) and 17 months OS (p=0.001). Seven weeks RE-CIST did not correlate with outcome.
SS 6.06
Conclusion:
The ADC ratio7w at WB-DWI was an independent predictor of PFS and OS for disseminated NET treated by 90 Y-DOTATOC and may be useful for early treatment assessment. To compare the diagnostic performance of transabdominal highresolution ultrasound (HRUS; combined low-and high-MHz transducers) for gallbladder cancer and differential diagnosis of neoplastic polyps compared with endoscopic ultrasound (EUS) and pathology. Material and Methods: From 125 patients who underwent both HRUS and EUS, our study included 29 pathologically proven gallbladder cancers (T1 = 7, T2 = 19, T3 = 3) including 15 polypoid cancers and 50 surgically proven polyps (neoplastic = 30, non-neoplastic = 20). We reviewed formal report and assessed the diagnostic performance for gallbladder cancer and differential diagnosis of neoplastic gallbladder polyps. Statistical analyses were performed using Chi-square tests. Results: Sensitivity, specificity, PPV, and NPV for gallbladder cancer were 82.7%, 44.4%, 82.7%, and 44% in HRUS and 86.2%, 22.2%, 78.1%, and 33.3% in EUS. In stage accuracy, HRUS correctly diagnosed tumor stage in 14, overstage in 4, and understage in 11. EUS correctly diagnosed tumor stage in 14, overstage in 3, and understage in 12. Sensitivity, specificity, PPV, and NPV for neoplastic polyp were 80%, 80%, 86%, and 73% in HRUS and 73%, 85%, 88%, and 69% in EUS. Single (8/20 vs. 21/30, p = 0.035) and larger (52.5 + 13.2 vs. 66.1 + 10.3, p = 0.000) polyp were common in the neoplastic polyp, but there was no significant difference in age (52.5 + 13.2 vs. 66.1 + 10.3, p = .079).
Transabdominal HRUS showed comparable performance for the diagnosis of gallbladder cancer and differentiating neoplastic polyps compared with EUS. HRUS is also easy to use following our routine ultrasound examination.
SS 6.09
Adverse biliary events following orthotopic liver transplantation: evaluation with MR cholangiography and MR imaging at 3T
To assess the diagnostic value of MR cholangiography (MRC) and MR imaging at 3T when evaluating biliary adverse events after orthotopic liver transplantation. Material and Methods: A series of 116 transplant subjects with suspected biliary complications (impaired liver function tests and/or biliary abnormalities on ultrasound) underwent MRI at 3T (GE-DISCOVERY MR750; GE Healthcare). After the acquisition of axial 3D dual-echo T1-weighted images and T2-weighted sequences (propeller and SS-FSE), MRC was performed through coronal thin-slab 3D-FRFSE and coronal oblique thick-slab SSFSE T2w sequences. DW-MRI of the liver was also performed using an axial spin-echo echo-planar sequence with multiple b values (150, 500, 1000, 1500 sec/mm²) in all diffusion directions. All MR images were blindly evaluated by two experienced abdominal radiologists in conference to determine the presence of biliary complications, whose final diagnosis was based on direct cholangiography, surgery and integrating clinical follow-up with ultrasound and/or MR findings. Results: In twenty-four patients no biliary abnormality was observed. The remaining ninety-two subjects were affected by one or more of the following complications: ischemic-type biliary lesions (n=42), anastomotic strictures (n=20), ampullary dysfunction (n=18), anastomotic leakage (n=2), stones, sludge and casts (n=36). The sensitivity, specificity, PPV, NPV and diagnostic accuracy of the reviewers for the detection of all types of biliary complications were 99%, 91%, 98%, 95% and 97%, respectively. Conclusion: MR cholangiography and MR imaging at 3T are reliable for detecting biliary complications after orthotopic liver transplantation.
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Contrast-enhanced MRI textural analysis in Crohn's disease is associated with histological markers of hypoxia and angiogenesis G. Bhatnagar, J. Makanyanga, B. Ganeshan, A. Groves, M. Rodriguez-Justo, S.A. Taylor; London/UK Purpose: Neoangiogenesis is well described in Crohn's disease (CD). Image textural analysis (TA) is related to angiogenic markers in some cancers. The purpose of the study was to explore TA of contrast-enhanced MRI in CD in comparison to hypoxia and angiogenesis markers. Material and Methods: Before ileal resection, 7 CD patients (3 male), mean age 38 years (19-75) underwent 3T MR enterography including axial T1 THRIVE 330 s post IV gadolinium. ROIs were placed in bowel destined for resection and subsequently matched to 28 histological section sites using MRI of the resected specimen. Expression of hypoxia (HIF 1alpha) and angiogenesis (VEGF) markers in epithelium and leukocytes was recorded. TA features were acquired using TexRAD software, which utilises an image filtration histogram technique. TA parameters and the presence of histological markers were compared using a Mann-Whitney U test. 
SS 7.02
withdrawn by the authors
SS 7.03
Prospective analysis of quantified terminal ileal motility using magnetic resonance enterography as a biomarker of active inflammation in Crohn's disease A. Plumb 
Amsterdam/NL
Purpose: Retrospective data show a moderate negative correlation between terminal ileal (TI) motility and Crohn's disease (CD) activity. We aimed to confirm this in a larger, multisite prospective cohort. Material and Methods: 95 patients with CD underwent 3T MR imaging at one of two sites (UK: 39 patients; The Netherlands: 56 patients) following oral 2% mannitol solution. 2D BTFE images were acquired and a polygonal ROI was drawn on the TI by an experienced radiologist blinded to clinical data. A validated optic-flow algorithm was used to quantify TI motility within this ROI. All patients subsequently underwent ileocolonoscopy (median 4 days after MRI) with TI biopsies graded by endoscopic acute inflammatory score (eAIS; 0-6). Spearman rank correlation and receiver-operating characteristic curves were used to examine the association between TI MRI motility and eAIS. Results: Median eAIS was 1.4 (range 0-4) and motility 0.25 (0.042-0.858), with no significant differences between institutions. There was a statistically significant negative correlation between the eAIS and the motility score (rho = -0.54, p <0.001). The area under the ROC curve for TI motility to classify patients with eAIS ± 1 (i.e. any active inflammation) was 0.83 (95%CI: 0.74-0.93); and the optimal operating point of motility was 83% sensitive and 81% specific for detection of endoscopic inflammation. Conclusion: MRI-quantified motility is sensitive and specific for histological TI inflammation. Furthermore, the degree of motility disturbance is negatively correlated with the severity of inflammation. Crohn's disease (CD) and underlying enteric dysmotility has been postulated. This prospective study investigated the relationship between MRI-quantified small bowel (SB) motility and patient symptom burden. Material and Methods: Fifty-four CD patients (median age 35 years, range 18-56) completed the Harvey Bradshaw Index (HBI) the day before MRI enterography. A coronal steady-state free precession breathhold motility sequence was acquired (1 s temporal resolution, slice thickness 1 cm), repeated to encompass the whole SB volume. An experienced radiologist drew regions of interest (ROI) in each cine block including all morphologically normal SB (i.e. excluding diseased bowel). A validated optic flow registration programme produced quantitative motility maps using the standard deviation of pixel Jacobian determinant. Global SB motility, expressed by mean and variance, correlated the HBI and components (well-being, pain, diarrhoea) using Spearman's rho for non-parametric data. Results: Mean HBI was 3 (range 0-16) and motility mean and variance were 0.33 (0.18 to 0.51) and 0.01 (0.0014 to 0.034), respectively. There was no association between mean motility and HBI (p >0.05). However motility variance was significantly negatively correlated with total HBI (rho = -0.45, P <0.001), well-being (rho = -0.4, p = 0.003), pain (rho = -0.27, p = 0.05) and diarrhoea (rho= -0.4, p = 0.0025). Conclusion: Reduced motility variance in morphologically normal small bowel correlates with patient symptoms, supporting underlying symptomatic pan-enteric dysmotility.
SS 7.05
Assessment of bowel wall enhancement for the diagnosis of intestinal ischemia in patients with small bowel obstruction: value of adding unenhanced CT to enhanced CT A.-M. Chuong, L. Corno, H. Beaussier, I. Boulay Coletta, G. Chatellier, M. Zins; Paris/FR Purpose: To evaluate the value of adding unenhanced (CT) to enhanced CT to assess decreased bowel-wall enhancement (DBE) for diagnosing intestinal ischemia in a large population with small bowel obstruction (SBO). Material and Methods: Two gastro-intestinal radiologists (A and B) performed retrospectively independent blinded reviews of 164 unenhanced and enhanced CT scans of 158 consecutive patients admitted for SBO. The diagnosis of ischemia was established either by the surgical and/or the histopathologic findings (80 cases) or the clinical follow-up (84 cases). DBE was assessed according to a three-point confidence scale, using first enhanced CT images alone and one month later both unenhanced and enhanced CT images. Results: In 41 of 164 (25%) CT scans, ischemia was confirmed at surgery and/ or histopathologic finding examination. The sensitivity of DBE was improved between the 2 reviews for both readers A (46.3% [19/41] [26/41] , p = 0.45). The positive likelihood ratio was increased for both readers A (11.4 vs. 13.5) and B (3.6 vs. 11.1). The mean confidence score was significantly (p <0.001) increased: 2.27 vs. 2.88 and 1.70 vs. 2.77 for readers A and B, respectively. The inter-observer agreement improved from fair (κ = 0.48) to excellent (κ = 0.89). Conclusion: Unenhanced CT, in addition to enhanced CT, increases the sensitivity, the positive likelihood ratio, the mean confidence score and the inter-observer agreement of the DBE sign for diagnosing intestinal ischemia complicating SBO.
SS 7.06
Changes in dynamic contrast-enhanced pharmacokinetic parameters reflect response to anti-TNF therapy in Crohn's disease G. Bhatnagar, D. Prezzi, N. Dikaios, R. Vega, S.A. Taylor; London/UK Purpose: To determine the utility of dynamic contrast enhancement (DCE) and diffusion-weighted (DWI) MRI in predicting and monitoring response to anti-TNF therapy in Crohn's disease (CD). Material and Methods: 27 CD patients (mean age 29 years, 11 F) underwent MRI enterography with DCE-MRI (coronal VIBE, 24 measurements/127 s) (n = 21) and DWI-MRI (5 B values 0 to 600) (n = 17) before (median 5 days) and after (median 83 weeks) commencing anti-TNF therapy. An experienced radiologist placed ROIs in the most inflamed bowel segment, matching pre-and post-therapy scans. Tofts modelling derived K trans (min-1), plasma volume v p and extracellular extra vascular volume v e . ADC was calculated. A gastroenterologist blinded to MRI defined patients as responders or non-responders at the time of follow-up MRI using physician global assessment (composite of clinical, biochemical, imaging and endoscopic parameters). Baseline MRI parameters and post-treatment changes were compared using Mann-Whitney test according to therapeutic response.
Results: Baseline K trans was not significantly different between responders (n = 15, median 0.26) and non-responders (n = 6), median 0.12, p = 0.38. However there was a significant difference between K trans change (median 52% fall in responders vs. median 165% increase in non-responders), p = 0.038. The remaining DCE parameters and ADC did not demonstrate any difference between responders and non-responders (p >0.05). Conclusion: DCE parameters nor ADC predict response to anti-TNF therapy. However responders show a significant fall in K trans compared to non-responders suggesting enteric perfusion reflects therapeutic response.
SS 7.07
Histological validation of ultrasonic features of acute and chronic inflammation in enteric Crohn's disease using surgical resection specimens G. Bhatnagar Portsmouth/UK Purpose: To explore the relationship between ultrasonic small bowel (SBUS) morphological observations in Crohn's disease (CD) and histopathological inflammation. Material and Methods: SBUS was performed in 10 CD patients (mean age 34 years (17-69), 6 males, 4 females) immediately prior to small bowel resection. Ultrasound characteristics including mural, mucosal and submucosal thickness; submucosal echogenicity (1 = reduced, 2 = increased, 3 = increased with bands) and clarity (0 = normal,1 = ill defined); mesenteric echogenicity (increased with (1) or without (2) fat wrap, 3 = stratified, 4 = reduced) and clarity (1 = well defined, 2 = ill defined, 3 = focal ill defined); Doppler signal (1 = increased focal, 2 = increased general) were scored in 41 sections by an experienced radiologist. Matching with histological sampling was made via scanning of the resected specimen. Parameters of acute (neutrophil number, depth, cryptitis and destruction, ulceration) and chronic (chronic inflammatory cell number, transmural lymphoid aggregates and depth, perineural inflammation) inflammation were scored by a histopathologist. Ultrasound and histological parameters were correlated using Pearson's correlation coeffecient. 
SS 7.08
Clinical significance of pneumatosis intestinalis: correlation of MDCT findings with patients' management and outcome S. Schmidt Kobbe, J.-F. Knebel, R. Meuli, M.-O. Treyvaud; Lausanne/CH Purpose: To evaluate the clinical significance of pneumatosis intestinalis (PI) including the influence on patients' management and outcome Material and Methods: Two radiologists in consensus reviewed CT examinations of 149 consecutive emergency patients (53 women, mean age 64 years) with PI of the stomach (n = 4), small (n = 68) and/or large bowel wall (n = 96). The extent of PI and possibly associated portomesenteric venous gas (PMVG) were correlated with other radiological and clinical findings, management, and final diagnosis. Results: The most frequent cause of PI (n = 80,53.7%) is bowel ischemia, followed by infection (n = 18, 12.1%), obstructive (n = 12,8.1%) and non-obstructive (n = 10, 6.7%) bowel dilatation, unknown aetiologies (n = 8,5.4%), drugs (n = 8,5.4%), inflammation (n = 7,4.7%), and others (n = 6,4%). The overall mortality was 41.6% (n = 62), mostly occurring with ischemia (n = 39, 54.2%) despite surgery in 51 patients (63.8%). The association of PMVG with PI significantly correlated with underlying ischemia (p = 0.001), like distribution of PMVG (p = 0.004). Absent bowel wall contrast enhancement was the only MDCT feature significantly associated with ischemia (p = 7.484 x 10 -6 ), unlike other MDCT findings. The degree of calcified atherosclerosis, evaluated on MDCT, significantly correlated with underlying ischemia (p = 0.024), unlike other cardiovascular risk factors (p = 0.723). Patients with PI due to ischemia had a significantly higher fatal outcome (p = 0.003), regardless of their age. Conclusion: In emergency patients, PI is caused by various intestinal disorders. Ischemia remains the most common aetiology with the highest mortality despite frequent surgery. PI with associated PMVG should alert the radiologist to think of ischemia.
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To operate or not to operate: the contribution of CT findings in small bowel obstruction in the determination of the need for surgery D. Oncel, B. Polat; Izmir/TR Purpose: To evalute the contribution of CT findings in small bowel obstruction in determining the need for surgery or conservative therapy. Material and Methods: We evaluated retrospectively a total of 110 patients (62 males, 48 females, mean age 62 years) who were admitted to the Emergency Department between January 2012 and October 2014 and diagnosed with small bowel obstruction with CT findings and clinical evaluation. The significance of CT findings, such as transition zone, faeces sign, mesenteric edema, free peritoneal fluid, strangulation, closed loop obstruction and air in portal vein, in determining the need for surgical treatment were evaluated statistically. Results: The patients were seperated into two groups as patients treated surgically (67 patients) and patients treated conservatively (43 patients). The transition zone sign, when observed alone, was not statistically significant in determining the need for surgery. But when observed together with at least one of the findings such as mesenteric edema or free peritoneal fluid, it had a higher specificity and was found to be statistically significant. Most of the patients with faeces sign were treated conservatively. However; strangulation, closed loop obstruction and air in the portal vein were considered as indications for surgery even if they were observed alone and found to be statistically significant. Conclusion: CT provides an important contribution to the diagnosis of small bowel obstruction and also in the guidance of appropriate treatment.
SS 7.10
Closed-loop small-bowel obstruction: precise diagnosis with multiplanar MDCT imaging with specific signs K. Hekimoglu, S. Arslan, M. Kirnap, M. Coskun; Ankara/TR Purpose: Closed-loop obstruction (CLO) is an uncommon clinical entity. The length of the CLO is variable, ranging from a short segment to several loops. Early diagnosis of this abnormality remains crucial in the decision whether to use surgical or medical management. Multidetector computed tomography (MDCT) has been shown to be useful in revealing the site and the cause of the obstruction with multiplanar imaging capability. The purpose of this study was to determine the diagnostic impact of multiplanar evaluation of MDCT in patients with CLO. Material and Methods: The MDCT findings of 53 patients with clinically suspected CLO were evaluated prospectively. MDCT exams were performed with 16 slices scanner with 3-dimensional reformatting at Workstation for multiplanar evaluation of CLO with specific MDCT findings.The diagnosis was correlated with the surgery. Results: Thirty-one patients were diagnosed with CLO with specific signs. All of them had dilated U/C-shaped bowel loops. Twenty patients had beak sign, ten had radial vessels distribution, eight had pneumatosis, four of them had whirl sign, and three patients had internal hernia which were demonstrated on coronal and sagittal multiplanar imaging. Twenty-five of the 31 patients underwent surgery. Adhesions were demonstrated to be the most important reasons for the CLO by surgery. Multiplanar MDCT had 94% sensitivity, 90% specificity, and 95% accuracy for the correct diagnosis of CLO. Conclusion: Multiplanar MDCT imaging is a valuable method for demonstrating the specific signs and precise diagnosis of CLO. 
SS 8.02
MR relative mean T2-signal intensity as a possible marker of response to neoadjuvant therapy and distant recurrence in moderate-to high-risk rectal cancer I. Santiago, R. Rocha, R. Theias, A. Gomes, A. Costa, T. Fiuza, V. Nunes; Amadora/PT Purpose: To evaluate the relation between staging MR T2-signal intensityderived parameters, response to neoadjuvant therapy and long-term patient outcome in moderate-/high-risk rectal cancer patients. Material and Methods: All rectal cancer patients with a preoperative staging pelvic MR who underwent long-course chemoradiotherapy (CRT) followed by total mesorectal excision (TME), diagnosed at our Institution between 01-01-2004 and 02-17-2014, were included, totaling 47 patients (64.8 ± 13.2years, 30 males). Staging MR high-resolution T2-weighted images were retrospectively evaluated by a single radiologist with 5 years of experience in pelvic MR. Signal intensity distribution was analyzed using representative regions of interest with a minimum area of 50 mm 2 (ROI50) (TROI50) and total tumor volume (TV); ROI50 of dense skeletal muscle was used as reference. Relative minimum, maximum and mean signal intensity values were calculated both for TROI50 and TV. Histopathologic and patient long-term outcome variables were analyzed. Results: A significant association between relative mean signal intensity using both TROI50 (2.43 ± 0.96 vs. 3.13 ± 0.97; p = 0.029) and TV (2,50 ± 1,17 vs. 3.37 ± 0.95; p = 0.009) on staging MR and distant disease recurrence was found. Relative mean signal intensities using both TROI50 and TV were significantly correlated to post-CRT tumor differentiation (r = -0.310, p = 0,037; r = -0.454, p = 0.002, respectively). Post-CRT tumor differentiation grade was higher in patients with distant recurrence (p = 0.012). Conclusion: Staging MR T2-derived relative mean tumor signal intensity may be an important marker of response to CRT and distant recurrence in moderate-to high-risk rectal cancer patients.
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Is diffusion-weighted imaging helpful in evaluating extramural tumor invasion in primary rectal cancer? S.H. Kim, J.-H. Yoon, Y. Lee; Busan/KR Purpose: To evaluate the added value of diffusion-weighted imaging (DWI) to T2-weighted images (T2WI) for evaluating extramural tumor invasion in patients with primary rectal cancer. Material and Methods: The institutional review board approved this retrospective study and waived the informed consent from patients. Seventy-two patients who underwent 1.5-T MRI including DWI (b = 0, 1000 s/mm 2 ) and subsequent surgery were included in this study. To evaluate the additional value of DWI, two blinded radiologists independently read the T2WI first, and then the combined set of T2WI and DWI. They recorded their confidence level using a 5-point scale regarding extramural tumor invasion. The diagnostic accuracy was calculated for each reviewer using a receiver operating characteristic (ROC) curve analysis. To evaluate the added value of DWI to T2WI for extramural tumor invasion, a pairwise comparison of ROC curves was used. Histopathologic results served as the reference standard for extramural tumor invasion. Results: The study population consisted of T1 (n = 11), T2 (n = 15), T3 (n = 43) and T4 (n = 3). The area under the ROC curve did not significantly increase after adding DWI to T2WI (for reader 1, from 0.961 to 0.982, P = 0.2118; for reader 2, from 0.931 to 0.929, P = 0.8770). Conclusion: Adding DWI to T2WI showed no additional diagnostic benefit for evaluating extramural tumor invasion in patients with primary rectal cancer.
SS 8.04
Follow-up with MRI of rectal cancer treated by TEM: recurrence detection and inter-observer reproducibility M. 
Roermond/NL
Purpose: Small rectal cancers can be treated with transanal endoscopic microsurgery (TEM). Post-operative changes make follow-up with MRI challenging. The aim of the study was to evaluate post-TEM-MRI at different time points for recurrence detection and assess interobserver reproducibility. Material and Methods: 38 patients underwent TEM (8 after CRT). MRI was performed every 3-4 months during follow-up and consisted of T2W-MRI ± DWI. 122 MRIs were performed with a mean of 3 MRI per patient. Seven patients recurred. MRIs were evaluated by 2 readers with different experience by confidence level (CL), scoring for recurrence, and reproducibility was evaluated with weighted-κ-statistics. Results: For all MRIs AUC for recurrence detection was 0.79 and 0.73 for T2W-MRI and 0.69 and 0.76 for DWI. During follow-up, AUC increased from 0.55 to 0.67 at T2W-MRI and from 0.57 to 0.73 for the expert. Interobserver reproducibility increased during follow-up for T2W-MRI from κ0.127 to 0.429. For DWI, reproducibility was fair (κ0.38-0.40). Nodal staging had stable moderate reproducibility (κ0 .53). At the first post-TEM-MRI higher CL scores were given at DWI than at T2W-MRI, and this difference disappeared from the second MRI. The number of equivocal scores decreased during follow-up. Isointensity in bowel wall and/or mesorectal fat was predictive for recurrence.
Conclusion:
The first post-TEM-MRI is difficult to assess. During follow-up, the accuracy for recurrence detection increases, because of comparison with earlier studies. There is a learning curve during follow-up that leads to more certainty. Reproducibility is fair-moderate, but increases during follow-up. Isointensity in bowel wall and/or mesorectal fat was predictive of recurrence.
SS 8.05
Automated and semi-automated diffusion-weighted MRI tumour volumetry to assess response to neoadjuvant therapy in rectal cancer 
SS 8.06
Dynamic contrast enhancement MRI combined with diffusion-weighted imaging for rectal cancer response assessment after neo-adjuvant chemoradiation P.P. Arcuri Purpose: This study retrospectively assessed the predictive potential of DCE-MRI combined with DWI for selecting patients with a favourable pathological response in rectal cancer after neo-adjuvant CRT. Material and Methods: We studied retrospectively 35 patients affected by locally advanced rectal cancer. The study consisted of two MRI exams, one pre-CRT and the other pre-surgery. MR imaging pre-contrast included T1-W TSE, T2-W TS and DWI using b-values of 0, 600 and 1000 s/mm 2 . Dynamic images were obtained by axial fat-sat THRIVE sequence. Fifteen dynamic series were acquired at 0-240 th s. Surgery was performed in all patients. Histopathology was considered as standard of reference for statistical evaluation. Quantitative evaluation of DCE-MRI was performed by SI-time curves, calculating the wash-in rate (WIR), maximum relative enhancement (RME), time-topeak enhancement (TTP) and wash-out rate (WOR). For the quantitative analysis of DWI, ADC values of the tumor were calculated and correlated with histologic grade. The values were compared using the Mann-Whitney U test. Results: Agreement between DWI and pathology was found in 21/35 patients (60%). 9 cases were understaged and 5 were overstaged. Agreement between post-contrast and pathology was found in 23/35 patients (66%). 5 cases were understaged and 7 were overstaged. DWI obtained sensitivity 74%, specificity 69%, PPV 41%, NPV 85% and accuracy 61%. Post-contrast obtained sensitivity 98%, specificity 81%, PPV=58, NPV=94 and accuracy 83%.
Conclusion:
In conclusion, this study shows that the addition of DWI to a DCE-MRI improves the performance and confidence of radiologists in selecting patients with a pathological complete tumor response after chemoradiation for locally advanced rectal cancer.
SS 8.07
Which images are clinically significant findings in constipated patients with pelvic floor dyssynergia? A guide to surgery H.J. Jeon, M.K. Seong, U.C. Park, Y.J. Kim, M.H. Yu, S.I. Jung, S.W. Park; Seoul/KR Purpose: The current study was designed to assess the defecographic characteristics and clinical significance of pelvic floor dyssynergia (PFD). Moreover, the standardized parameters for the diagnosis of PFD were analysed. Material and Methods: Studies included defecography and cinedefecography (n = 553), anal manometry (n = 237), and colonic transit time study (n = 85). 317 patients (57.1%) were found to have pelvic outlet obstruction. Diagnostic criteria were based on 3 factors: 1) persistent angulation of the posterior rectal wall, 2) poor emptying of the rectum, 3) poor opening of the anal canal. PFD was evaluated by 3 different doctors. Cronbach's α test for reliability was used to define the internal consistency of the findings. Cohen's k test was used to define agreements between each of the defecographic findings and results of other tests. Results: Findings were categorized into three factors: 1) persistent angulation of the posterior rectal wall in 33 (34%); 2) poor emptying of the rectum in 61 (63%); 3) poor opening of the anal canal in 33 (34%). Internal consistency of defecographic three factors was good (α = 0.78). Agreements between each defecographic findings and each result of other tests were all poor. Defecography as imaging test has been considered to be a sensitive and specific measurement of PFD when it documents the three diagnostic factors.
Conclusion:
The present series provided different anatomical, functional and clinical profiles of patients with PFD. Parameters to define the internal consistency of defecographic findings were useful for the diagnosis of PFD.
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Role of conventional evacuation proctography in the evaluation of faecal evacuation disorder with anorectal manometric correlation A. Chatterjee, S. Kumar; Lucknow/IN Purpose: To evaluate the role of conventional evacuation proctography (EP) in the evaluation of faecal evacuation disorder (FED) and to find any correlation with the findings of anorectal manometry. Material and Methods: Conventional EP was performed in consecutive 36 patients with clinical diagnosis of faecal evacuation disorders. Anorectal angle (ARA) and the distance between the anorectal junction and pubococcygeal line were recorded at rest and during squeezing, straining and defecation. Anorectal manometry and balloon evacuation test (BET) were done in 28 patients and the findings recorded. Results: Percentage change in ARA from rest to defecation was lower in patients with manometric diagnosis of anismus and abnormal BET (average 16%, range: 0-41%) than in patients without the diagnosis (average 23%, range: 5-84%). In the first group, 3 patients had paradoxical increase in ARA during straining. There was mild positive correlation (correlation co-efficient 0.3) between the squeeze pressure of the external sphincter and percentage of decrease in ARA from rest to squeeze. No correlation was obtained between resting ARA and basal sphincter pressure. Additional diagnoses made in EP were rectal descent (n = 18), anterior rectocele (n = 5) and intussusception (n = 4). Among patients with rectal descent, 3 patients (16.7%) had a descent only during straining or defecation. Conclusion: Conventional EP has good correlation with anorectal manometry in the evaluation of FED and also demonstrates additional findings such as rectal descent, rectocele and intussusception.
SS 8.09
Comparison between two different magnetic resonance defecography techniques for evaluating pelvic floor disorders: air-balloon versus gel rectal filling F. Maccioni, V. Buonocore, N. Al Ansari, C. Catalano; Rome/IT Purpose: To compare 2 different functional MRI techniques, based on different rectal filling techniques, for evaluation of pelvic floor disorders. Material and Methods: 26 patients with pelvic floor dysfunctions underwent 2 different rectal filling techniques during the same procedure at 1.5 T. The first MRI technique, the "air-balloon" technique (AB-DPF MRI) is based on the distension of the rectum with room air (Foley catheter); the other one, the gel-filling technique (GF-DPF MRI) is based on the use of ultrasound gel for rectal filling. Images were acquired at rest, during prolonged contraction and straining with balanced or T2-weighted sequences on different planes. For both MR techniques, rectal prolapse, rectocele, cystocele and colpocele were evaluated in all patients by 2 radiologists and graded. For intussusception and enterocele, only the presence or the absence was reported. Results: GF-DPF MR showed 25 rectal prolapses, 21 rectoceles, 20 cystoceles, 8 colpoceles, 21 intussusceptions and 7 enteroceles. AB-DPF MRI showed 24 rectal prolapses, 23 rectoceles, 20 cystoceles, 10 colpoceles, 18 intussusceptions and 11 enteroceles. The air-balloon technique missed 1 rectal prolapse; a higher number of rectoceles, colpoceles and enteroceles were depicted with AB-DPF MRI. The capability of the 2 techniques for intussusception was not statistically different ( p = 0,12). Conclusion: In our experience, both techniques are valuable and show favorable and unfavorable aspects; they may be associated in the same imaging session to reach maximal accuracy.
SS 8.10
The , 12 patients with a mean age 61.8 ± 11.5 years were enrolled with imaging features of phlebosclerotic colitis at Taipei Veterans General hospital and Wei Gong Memorial hospital. The episodes of active disease ranged from 0 to 27 (1 ± 1.75, median ± interquartile). The calculated scores using the scoring system ranged from 9 to 33 (18 ± 13, median ± interquartile). The Spearman's correlation revealed that the numbers of episodes of active disease of phlebosclerotic colitis had significantly positive correlation with the severity of the calcifications of mesenteric veins (rho = 0.619, P < 0.05).
Conclusion:
The extent of mesenteric venous calcifications has positive relationship with the frequency of clinical symptoms of active disease in the patients with phlebosclerotic colitis. There was no procedure-related mortality. Two patients (2/18, 11%) died due to unrelated illness (one with metastatic gastric carcinoma and the other patient with recurrent sepsis on subsequent admission). The limitation of the study is that we do have age-matched control of patients who had laparotomy or laparoscopic treatments for comparison. Conclusion: Percutaneous image-guided drainage is a safe and effective treatment option for patients with perforated gall bladder and should be considered as a first-line treatment. If needed, cholecystectomy can be planned after the resolution of the acute episode.
SS 9.08
Pre-operative percutaneous transhepatic biliary drainage in choledochal cysts S. Kumar, A. Gupta, A. Chatterji; Lucknown/IN Purpose: To evaluate the role of percutaneous transhepatic biliary drainage (PTBD) in the perioperative management of choledochal cysts.
Material and Methods:
Retrospective evaluation of the records of 10 consecutive patients with choledochal cysts were performed who were treated with PTBD in the pre-operative period. Results: 6 patients had type 1 and 4 patients had type IVA choledochal cysts. Age of the patients varied from 5 to 60 years. Indication of drainage was cholangitis in 5 patients and reduction of hyperbilirubinemia (average 14 mg/dL, range 9-21 mg/dL) in 5 patients. In all cases, 8-10 F Malecot catheters were inserted under ultrasound and fluoroscopic guidance using Seldinger technique. All procedures were done in local anaesthesia and conscious sedation. In 8 patients, segment 3 hepatic duct was drained and in one case, segment 8 duct was drained. In 2 patients, internalisation using ring biliary catheter (8F) was done prior to surgery. 2 patients were lost to follow-up. Definitive surgery was done in 8 patients after an average time period of 36.75 days (range 20-91 days) after the cholangitis subsided or hyperbilirubinemia is controlled. Catheter dislodgement occurred in 1 patient and self-resolving hemorrhage occurred in 1 patient.
Conclusion:
Patients with choledochal cysts presenting with cholangitis and/ or very high bilirubin levels may be safely and effectively managed by PTBD with or without internalisation using ring biliary catheters. 
Paris/FR
Purpose: To develop and optimize a Magnetization Transfer (MT) sequence designed to be applied ex vivo, on a murine model and in humans, to assess the influence of liver steatosis and fibrosis on the MT Ratio (MTR). Material and Methods: A MT sequence was tested at 1.5T and 3T in 3 distinct ex vivo samples-including fresh liver, fat liver and muscle-as well as in a murine model of liver steatosis (Foz/foz obese mice and controls), and in 100 patients with documented liver cirrhosis as well as in 161 control patients. Liver fat was determined by T2* and T1-corrected 1H spectroscopy. The MTR was assessed and compared in between tissues (Mann-Whitney, Anova or Kruskal-Wallis when appropriate). The influence of the B0 field and offset, liver steatosis and fibrosis were assessed in sub-group analysis.
Results: Ex vivo, the MTR in fresh muscle was significantly superior to that of fresh liver and to that of fat liver (p<0.02). The MTR significantly increased with reduced offset and with increased B0. Steatotic foz/foz mice showed significantly reduced MTR compared to controls (p<0.01). In humans, neither fibrosis nor the levels of steatosis had an influence on MTR. Conclusion: Although liver fat significantly reduces MTR in high-grade fatty liver observed in animal models of obesity, the levels of liver fat and fibrosis observed in humans have no impact on MTR.
SS 10.03
Assessment of an Hi SNR C-MRI sequence for use in determination of low hepatic proton density fat fraction (PDFF) in adults C.A. Hooker, W.M. Haufe, R. Loomba, M.S. Middleton, C. Sirlin, G. Hamilton; San Diego, CA/US Purpose: To assess in adults the accuracy of complex-MRI (C-MRI) and high-SNR (Hi-SNR) C-MRI to determine hepatic proton density fat fraction (PDFF), at PDFF <10%.
Material and Methods:
In this prospective study, an Hi-SNR C-MRI sequence was developed by increasing slice thickness from 8 to 10 mm, and decreasing matrix from 224x128 to 128x92. Adult subjects with known or suspected non-alcoholic fatty liver disease (NAFLD) underwent 3T MRIs including C-MRI and magnetic resonance spectroscopy (MRS). C-MRI PDFF values were determined by averaging the observed value in three regions of interest placed on C-MRIs co-localized to the MRS voxel location, one slice above and below that location. Linear regression models were used to assess accuracy of C-MRI PDFF using MRS PDFF as reference. Results: 56 adults enrolled (25 M, 30 F; age 51.3 ± 12.6 yrs). Regression analysis of Hi SNR C-MRI using MRS as reference had a slope, y-intercept and R 2 value, respectively, of 0.936, 0.307% and 0.984 for all subjects; and 0.985, -0.231% and 0.942 for 22 subjects with PDFF <10%. Those values for C-MRI were 0.978, -0.055% and 0.983 for all subjects; and 0.914, 0.051% and 0.681 for 22 subjects with PDFF <10%.
Conclusion:
In adults with known or suspected NAFLD, correlation of Hi-SNR C-MRI PDFF with MRS was higher than that for just C-MRI, for PDFF values <10%. 
SS 10.04
Scientific Sessions
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Material and Methods: In this prospective, cross-sectional study, 200 children (ages 8-18 years) underwent 3T MR examinations which included M-MRI, C-MRI, and T1-independent, T2-corrected, single-voxel, STEAM MRS. Both MRI methods acquired 6 echoes at low flip angles. T2* corrected PDFF parametric maps were generated. PDFF values were recorded from regions of interest drawn on the maps and co-localized to the MRS voxel location. PDFF values estimated by M-MRI and C-MRI were plotted against MRS-measured PDFF values. Regression analyses were performed. Regression accuracy indices and 95% confidence intervals (CIs) were computed. Results: Mean MRS-measured PDFF was 13.4% (range 0.9-41.9%). C-MRI PDFF estimation was highly accurate (regression slope 0.981 ± 0.024; intercept -0.017 ± 0.396%; R 2 0.972). The 95% CIs for slope and intercept included 1 and 0, respectively. M-MRI PDFF was also highly accurate (slope 0.991 ± 0.022; intercept 0.729 ± 0.359%; R 2 0.976). The 95% CI for slope included 1, but the 95% CI for intercept did not include 0, indicating small systematic underestimation by M-MRI. Conclusion: Both M-MRI and C-MRI accurately measure PDFF in children. Although both techniques were accurate with MRS as reference, M-MRI showed small, systematic underestimation.
SS 10.05
Association of hepatic histologic features with MR spectroscopy-derived hepatic fat and water T1 and T2 estimates in adults with non-alcoholic fatty liver disease A. Schlein, P. Manning, C. Sirlin, M.S. Middleton, T. Wolfson, G. Hamilton; San Diego, CA/US Purpose: To assess possible associations between hepatic histologic features of non-alcoholic fatty liver disease (NAFLD) and magnetic resonance spectroscopic (MRS)-derived T1 and T2 fat and water estimates in adults. Material and Methods: Enrolled subjects receiving standard-of-care liver biopsy for evaluation of NAFLD were consented for 3T liver MR examinations. Their biopsies were scored based on NASH CRN criteria. A custom MRS sequence that acquired 32 spectra across a range of TR and TE in a 21 s breath hold was used to estimate the T1 and T2 of liver fat and water. Spectra were analyzed offline using jMRUI. Fat and water T1 and T2 were estimated by nonlinearly fitting the standard MR decay function to the fat and water peak areas. The relationship between T1 and T2 values of fat and water, and histologically determined steatosis, inflammation, ballooning, and fibrosis were examined using Spearman's correlation with Bonferroni correction. Results: 101 adults were enrolled in this study. Water T1 and T2 showed a positive association with fibrosis (rho = 0.35 and 0.39, p < 0.0005 and 0.0001, respectively; significant after Bonferroni correction). Fat T2 showed a positive association with steatosis (rho = 0.478, p < 0.0001). There were no other statistically significant associations.
Conclusion:
In adults with NAFLD, hepatic fibrosis shows association with MRS-estimated water T1 and T2 and steatosis with fat T2. This may contribute to non-invasive detection and monitoring of NALFD.
SS 10.06
Volumetric estimation of liver function based on Gd-EOB-DTPA-enhanced MR-relaxometry M. 
Erlangen/DE
Purpose: To determine whether liver function expressed by the indocyanine green clearance (ICG) could be estimated quantitatively from hepatic magnetic resonance (MR)-relaxometry with Gd-EOB-DTPA. Material and Methods: 113 consecutive patients underwent an ICG clearance test and Gd-EOB-DTPA-enhanced MR including MR-relaxometry. After acquisition of a B1 map for inline correction of B1 inhomogeneities a prototypical transverse 3D VIBE sequence with inline T1 calculation was acquired prior and 20 minutes post-Gd-EOB-DTPA administration. The reduction rate of T1 relaxation time (rrT1) between pre-and post-contrast images and the liver volumeassisted index of T1 reduction rate (LVrrT1) were evaluated. The plasma disappearance rate of ICG (ICG-PDR) was correlated with the liver volume (LV), rrT1 and LVrrT1, providing an MRI-based estimated ICG-PDR value (ICG-PDR est ). Results: Simple linear regression model showed a significant correlation of ICG-PDR with LV (r=0.31; p=0.001), T1 post (r=0.63; p<0.001) and rrT1 (r =0.84; p<0.001). Assessment of LV and consecutive evaluation of multiple linear regression model revealed a stronger correlation of ICG-PDR with LVrrT1 (r=0.90; p<0.001), allowing for the calculation of ICG-PDR est . Conclusion: Liver function as determined using ICG-PDR can be estimated quantitatively from Gd-EOB-DTPA-enhanced MR-relaxometry. Volume-assisted MR-relaxometry has a stronger correlation with liver function than does MR-relaxometry. Global and regional liver function may be visualized by Gd-EOB-DT-PA-enhanced MRI, which might be of importance for planning liver resections.
SS 10.07
Liver histology and diffusion-weighted MRI measurements in children with non-alcoholic fatty liver disease: a MAGNET study P. Manning ). Images were reconstructed using an advanced method based on the BetaLogNormal distribution to reduce bulk motion artifact confounding effects. Three parameters were measured in the right hepatic lobe: apparent diffusion coefficient (ADC) assuming exponential decay, and diffusivity (D) and perfusion fraction (F), assuming bi-exponential intra-voxel incoherent motion. Biopsies were scored using NASH CRN criteria. Associations between histologic features and DWI-measured parameters were tested using multivariable linear regression. Results: Sixty-three children (45 boys, mean age 12 yrs, range 9-17 yrs) with biopsy-proven NAFLD were enrolled in this study. The estimated means ± standard deviations (and ranges) were: ADC 1.3 ± 0.2 (0.9 -1. ]) were quantitatively evaluated by compartment model analysis of dynamic CT. The correlation between F stages and each of these hemodynamic parameters, plus the diameter of the spleen (R), was evaluated statistically. Results: Analysis of variance revealed that there were significant differences in R (P < 0.01), K 1 (P < 0.01) and 1/k 2 (P < 0.01) according to F stage. As a result of stepwise regression analysis, R and 1/k2 were found to be independent explanatory variables on F stage (F = 0.033 [R (mm)] + 0.035 [1/k 2 (s)] -2.62). 1/k 2 was significantly longer in the patient with cirrhosis (43.5 s) compared to the other F stages (F0: 30.1 s, F1: 33.6 s, F2: 32.1 s, F3: 34.8 s). Conclusion: 1/k 2 of the spleen can be longer with progression of liver fibrosis; therefore, 1/k 2 of the spleen can be a significant predictor for cirrhosis, independent of splenomegaly.
SS 10.09
Validation and reproducibility of a novel method to measure total liver and hepatic arterial blood flow using phase-contrast MRI M. Chouhan, A. Bainbridge, N. Davies, R. Jalan, S. Walker-Samuel, M. Lythgoe, R. Mookerjee, S. Punwani, S.A. Taylor; London/UK Purpose: Non-invasive measurements of total liver blood flow (TLBF) and hepatic arterial flow (HAF) would be valuable in the assessment of portal hypertension. The purpose of this study was to validate and test the reproducibility of a novel method using phase-contrast MRI (PCMRI) measurements of the inferior vena cava (IVC) and portal vein (PV) to estimate TLBF and HAF.
S567
Material and Methods: Fasted healthy volunteers (n = 13) underwent PV, HA, proximal and distal IVC breath-hold,cardiac-gated 2D cine-PCMRI (5 mm slice thickness, α = 10˚, 256 x 256 (FE x PE)) at 3 T, with velocity encoding settings of 40, 60 and 80 cm/s. TLBF was estimated by subtracting proximal IVC flow (above renal, but below hepatic venous inlets) from distal IVC flow (above hepatic venous inlets, but below the IVC-right atrial junction). HAF was estimated by subtracting PV flow from estimated TLBF. Estimated flow measurements were validated with direct PCMRI measurements of PV and HA inflow. Reproducibility scans were conducted after 1 week (n = 11). Results: Significant correlations between estimated TLBF (r = 0.8967; p < 0.0001), estimated HAF (r = 0.5998; p = 0.0019) and estimated HA fraction (r = 0.5713; p = 0.0035) and their directly measured counterparts were observed. No significant differences between the mean estimated and directly measured TLBF (85.66 ± 5.702 vs. 89.97 ± 5.669 ml/min/100 g; p = 0.1087), HAF (7.502 ± 3.214 vs. 11.82 ± 1.669 ml/min/100g; p = 0.1087) and HA fraction (7.466 ± 4.201 vs. 14.08 ± 2.082%; p = 0.0686) were observed. The coefficients of reproducibility for estimated TLBF were comparable to directly measured TLBF (31.60 vs. 29.56 ml/min/100g), but larger for estimated HAF (28.77 vs. 19 .53 ml/min/100g) and estimated HA fraction (45.13 vs. 21.76%) relative to directly measured counterparts. Conclusion: Our methods can successfully estimate TLBF and HAF. Measurements validate with direct inflow measurements, but the reproducibility of the estimated HAF and fraction is compromised by error propagation.
SS 10.10
Incremental 
Material and Methods:
Preoperative hepatic vein embolization (HVE) was performed in 10 patients who had an inadequate liver hypertrophy after portal vein embolization (PVE). The right and/or medial HV was/were embolized using Amplatzer vascular plugs. Results: Of the 10 patients, 8 had secondary lesions of colorectal cancer, 1 had cirrhosis with hepatocellular carcinoma and the last one had a hilar cholangiocarcinoma. The ratio between the future remnant liver volume and nontumoral liver total volume was 23.8% ± 9% before PVE, 30% ± 7% 4 weeks after PVE, and 37.4% ± 7% 4 weeks after HVE. The patients underwent HVE on average 54 ± 15 days after PVE. Surgery could be performed in 5 patients 122 ± 22 days after PVE. No complications related to HVE have been reported. Of the 5 patients who underwent surgery, 1 died of post-operative liver failure. The other 5 patients were not operated because of major tumor progression.
Conclusion:
Preoperative HVE in addition to PVE seems to be a safe and effective technique to increase hypertrophy of the future remnant liver and can make some selected patients eligible for major hepatic surgery.
SS 11.03
Comparison between radiofrequency ablation and surgical resection using propensity score matching for hepatocellular carcinoma within Milan criteria A. Hocquelet Y glass microsphere radioembolization as a treatment of unresectable intrahepatic cholangiocarcinoma, with or without chemotherapy, and compare it with the results of chemotherapy alone. Material and Methods: We retrospectively analyzed data from patients treated at our institution with 90 Y-radioembolization for unresectable intrahepatic cholangiocarcinoma without extrahepatic spread. We compared the results with those of the patients with locally advanced non-extrahepatic cholangiocarcinoma treated at our institution with chemotherapy before 90 Y-radioembolization was available. The response was evaluated by CT scan, using RE-CIST1.1. Toxicity was retrospectively graded using NCI-CTCAE v4. Survival data were analyzed using the Kaplan-Meier method with the log-rank test. Y-radiembolization went to surgery (20%) and grade 3 adverse events were reported in 3 (10%). Conclusion: A strategy including 90 Y-radioembolization seems to significantly improve survival in patients with unresectable intrahepatic cholangiocarcinoma, compared to chemotherapy alone.
SS 11.07
Radiofrequency ablation of hepatocellular carcinoma: mono-or multipolar? V. Cartier, J. Boursier, J. Lebigot, F. Oberti, I. Fouchard, C. Aubé; Angers/FR Purpose: Thermo-ablation by radiofrequency is recognized as a curative treatment for early-stage hepatocellular carcinoma (HCC). However, local recurrence may occur because of incomplete peripheral tumor destruction. Multipolar radiofrequency has been developed to increase the size of the maximal ablation zone. We aimed to compare efficacy of monopolar and multipolar radiofrequency for the treatment of HCC and determine factors predicting failure. Material and Methods: 171 consecutive patients with 214 HCCs were retrospectively included. 158 tumors were treated with an expandable monopolar electrode and 56 with a multipolar technique using several linear bipolar electrodes. Imaging studies at 6 weeks after treatment, then every 3 months, assessed local effectiveness. Radiofrequency failure was defined as persistent residual tumor after 2 sessions (primary radiofrequency failure) or local tumor recurrence during follow-up. Results: Imaging showed complete tumor ablation in 207 of 214 lesions after the first session of radiofrequency. After a second session, 2 cases of residual viable tumor were observed. During follow-up, 46 local tumor recurrences occured. Thus, radiofrequency failure occurred in 48/214 (22.4%) cases. By multivariate analysis, technique (p<0.001) and tumor size (p=0.023) were independent predictors of radiofrequency failure. Failure rate was lower with the multipolar technique for tumors <25mm (p=0.023) and for tumors between 25 and 45 mm (p=0.082). There was no difference for tumors ≥45mm (p=0.552). Conclusion: Compared to monopolar radiofrequency, multipolar radiofrequency improves tumor ablation with a subsequent lower rate of local tumor recurrence.
SS 11.08
Percutaneous radiofrequency ablation of hepatocellular carcinoma: a comparison of fusion imaging guidance to conventional sonography guidance C.A. Liu, N.-C. Chiou, Y.-Y. Chiou; Taipei/TW Purpose: To review our experience with percutaneous radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) and evaluate the guided method as a predictor of the ability to achieve complete necrosis by imaging criteria. Material and Methods: Over a 2-year period, 146 patients with HCC who underwent percutaneous RFA were randomly assigned to fusion imaging and conventional sonography-guided ablation group.The contrast enhancement on CT was interpreted as complete coagulation necrosis. The relationship between guided methods (fusion imaging and conventional sonography-guided ablation) and the tumor location (peripheral and nonperipheral lesion) was identified using Chi-squared analysis. A logistic regression analysis was used to pick up the factors statistically correlated with technical success. Results: All 138 tumors underwent complete necrosis. A significant technical successful rate showed when comparing imaging fusion and conventional sonography-guided ablation on the tumors in peripheral lesion. A guided method also was a significant predictor (p = 0.024) toward predicting getting technical success (odds ratio: 3.270; 95% CI, 1.172-9.118), whereas the location showed a nonsignificant result (p = 0.471) of complete necrosis. Conclusion: Fusion imaging is a promising predictor for HCC in patients who are candidates for percutaneous RFA. There is a significant technical success on the tumors in peripheral lesion when using fusion imaging.
SS 11.09
Endovascular management of postpancreatectomy hemorrhage M. Ronot, E. Pottier, S. Gaujoux, L. Barbier, M.-P. Vullierme, A. Sauvanet, V. Vilgrain; Clichy/FR Purpose: To evaluate the efficacy of endovascular management of post-pancreatectomy hemorrhage (PPH). Material and Methods: Between 2005 and 2013, patients referred for endovascular treatment of PPH were included. Pretreatment CT scans were reviewed. Active bleeding, pseudo-aneurysm, arterial stenosis, and culprit artery were recorded. Endovascular procedures were classified as successful (bleeding origin identified and treated), failure (bleeding incompletely treated), and no-treatment (no vascular abnormality, no treatment performed). Factors associated with rebleeding were analyzed by uni-and multivariate analysis. Results: 69 patients (53 men, mean 58.5 years (32-75)) were included. CT showed 27 (39%) active bleeding, 25 (36%) pseudo-aneurysms, 2 (3%) arterial stenosis. In 22 (32%) cases, no culprit artery was found. Procedures were classified as successful, failure, or no-treatment in 48 (70%), 9 (13%), and 12 cases (17%). 30 patients (44%) experienced rebleeding (median 2 days (range S569 0-46)). Rebleeding rates were 29%, 58%, and 100% in success, no-treatment or failure (p<0.001), respectively. Patient management during angiography was the only factor associated with rebleeding (success vs. failure p<0.001; success vs. no-treatment p=0.09, no-treatment vs. failure p=0.04, overall p<0.001). Rebleeding was treated by endovascular treatment, surgery, or both, in 12 (40%), 11 (37%) and 7 (23%) cases, respectively. Overall, 72% of the patients were successfully treated by endovascular procedures alone. Conclusion: Rebleeding is associated with initial success of the embolization. The majority of patients were successfully treated by endovascular approach alone.
SS 11.10
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT M. D Peschiera del Garda/IT Purpose: To test the correlation between necrosis extent at CT and CA 19.9 serum levels as a possible outcome predictor after radiofrquency ablation (RFA) of unresectable pancreatic adenocarcinomas. Material and Methods: 51 patients with unresectable pancreatic adenocarcinoma were prospectively treated with RFA. CT exam was performed one week after RFA, while CA 19.9 assessment was performed after one month. Percentage necrosis extent at CT between patients with reduced/stable or increased CA 19.9 was compared with t-test. Results: CA 19.9 levels were reduced 1 month after RFA in 26/51 (51%) patients, while were stable in 12/51 (24%). 13 patients (25%) presented increased CA 19.9 levels. Mean percentage necrosis difference between patients with stable or <30% reduced CA 19.9 levels and those with >30% reduced CA 19.9 levels was statistically significant (p<0.05). The mean necrosis extent was 43% in patients with >30% CA 19.9 reduction. Conclusion: RFA of unresectable pancreatic adenocarcinoma induces cytoreduction, as showed by CA 19.9 reduction. It seems that the larger is the ablated area, the more consistent is CA 19.9 reduction. To achieve a reduction greater than 30% in CA 19.9 levels, more than 40% of the lesion must be treated.
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Image quality and diagnostic performance of dual-source CT with spectral imaging in hepatocellular carcinoma: rad-path correlation
To evaluate image quality and diagnostic accuracy of dual-source CT (DSCT) in the diagnosis of hepatocellular carcinoma (HCC) in a series of transplanted cirrhotic patients. Material and Methods: We searched our database for all cirrhotic patients who underwent DSCT with spectral imaging in late arterial phase, <120 days before liver transplantation (LTx). Three sets of images (A: 140kVp polychromatic; B: 70keV monochromatic; C: "iodine-based" material decomposition) were reviewed, assessing image quality (scale 1-5), lesion conspicuity (scale 1-3), number of lesions and lesion-to-liver contrast-to-noise ratio (CNR). Using the pathological findings on the explanted livers as standard of reference, sensitivity, specificity, positive and negative predictive values and accuracy were assessed and compared by DeLong method. Results: 35 patients were included, with 23 HCC nodules pathologically diagnosed in 18 (51.4%) patients (mean diameter 20.4±8.9 mm). Group B showed non-significantly higher image quality (1.11±0.40) compared to groups A (1.2±0.58) and C (1.17±0.38). Lesion conspicuity scores were 1.59±0.79, 1.23±0.56 and 1.23±0.44 for groups A, B and C, respectively (P>.05). CNR was significantly (P<.05) higher in group C (4.5±3.5) compared to groups A (2±0.9) and B (2.8±1.5). On the nodule-by-nodule and patient-by-patient analyses, group C had the highest diagnostic accuracy (area-under-the-curve, AUC 0,90-0,95), compared to groups A (AUC 0.81-0.84; P=.04/.036) and B (AUC 0.85-0.89; P=.16/.16).
Conclusion:
Spectral DSCT provides high-quality images; iodine-based datasets allow the confident diagnosis of HCC with >85% sensitivity and >95% specificity.
SS 12.02
Interobserver variability of gadoxetic acid-enhanced MRI for the non-invasive diagnosis of hepatocellular carcinoma using KLCSG-NCC guidelines: comparison with multiphasic MDCT I. Joo 
Seongnam/KR
Purpose: To evaluate interobserver variability of gadoxetic acid-enhanced MRI with comparison of that of multiphasic MDCT for the non-invasive diagnosis of hepatocellular carcinoma (HCC) using the 2014 Korean Liver Cancer Study Group (KLCSG) and the National Cancer Center (NCC) guidelines which include gadoxetic acid-enhanced MRI. Material and Methods: In this retrospective study, we included 146 patients with chronic liver disease presenting with 153 pathologically proven HCCs (≥1 cm) who had undergone both gadoxetic acid-enhanced MRI and multiphasic MDCT. Three radiologists independently determined the presence of typical imaging features of HCCs including arterial hyperenhancement, washout on portal venous and/or delayed phases, and pseudocapsule on MRI and MDCT, respectively. Interobserver agreement for each imaging feature and KLCSG-NCC diagnosis of HCC on MRI and MDCT were assessed by Fleiss kappa test. Results: Interobserver agreement of arterial hyperenhancement, washout, and pseudocapsule was moderate to substantial with gadoxetic acid-enhanced MRI and poor to moderate with MDCT. According to KLCSG-NCC, typical enhancement pattern was found in 92.8%, 92.2%, and 83.0% of HCCs on MRI; and 86.9%, 83.7%, and 69.9% on MDCT by reviewers 1, 2, and 3, respectively. Interobserver agreement for KLCSG-NCC either by MRI or MDCT was moderate (0.50, 95% confidence interval [CI] of 0.41-0.59; and 0.49, 95% CI of 0.40-0.58, respectively). Conclusion: KLCSG-NCC guidelines for the non-invasive diagnosis of HCC showed moderate inter-observer variability both by gadoxetic acid-enhanced MRI and MDCT. Results: Median OS was 22.7 months. At multivariate analysis, negative independent prognostic factors for OS were age >66 years (HR 1.79; P=.005), ascites (HR 2.35; P=.005) and progressive disease after TACE (HR 4.66; P<.0001), while positive independent prognostic parameters were maximum total HCC diameter according to mRECIST ≤60 mm (HR: 0.49; P=.001) and complete response after TACE (HR 0.64; P=.04). A 9-point scale score (range -3 to +6) was created, and three groups of patients were identified. Patients with scores <0 had a significantly longer OS (40.2 months, group A), compared to patients with scores =0 (23.3 months, group B) and scores >0 (13.3 months, group C) (A versus B, P=.0009; B versus C, P=.0026).
Conclusion:
Combining pre-and post-TACE parameters, our scoring system enables a simple stratification of intermediate-stage HCC patients that could be helpful for treatment planning.
SS 12.04
HCC differentiation: quantitative MRI study of tumor enhancement on Gd-BOPTA-enhanced hepatobiliary phase
To asses the added value of Gd-BOPTA-enhanced hepatobiliary phase imaging to distinguish hepatocellular carcinomas according to their pathological differentiation. Material and Methods: This study had IRB approval and the requirement for informed consent was waived. Twenty-one patients with 24 resectable HCC BCLC A (5 well differentiated, 10 moderately differentiated and 6 poorly differentiated) naïve of any treatment, and treated by orthotopic liver transplantation or hepatectomy were included in this prospective, monocentric study. All patients underwent a preoperative liver MRI after Gd-BOPTA injection included delayed hepatobiliary phase acquisitions. Two readers reviewed all images in terms of signal intensity (SI) features on unenhanced, and hepatobiliary phase images to establish the lesion-to-liver contrast enhancement ratio (LLCER). The LLCER was compared according to pathological differentiation (Mann-Whitney, ROC). Results: The LLCER of well-differentiated HCC (mean 46.01% ± 45.78) was significantly higher than that of moderately to poorly differentiated HCC (mean -22.62% ± 16.17) (p<0.0008). 100% of well-differentiated HCC had a positive LLCER and 100% of moderately to poorly differentiated HCC had a negative LLCER. Using a cutoff value of +3% yielded a 100% specificity and sensitivity for discriminating well-differentiated from moderate to poorly differentiated HCC. Conclusion: LLCER at the hepatocyte phase after Gd-BOPTA injection allows the differentiation of well-differentiated from moderately to poorly differentiated HCC.
SS 12.05
SS 12.06
Arterio-portal shunts in the cirrhotic liver: CT perfusion for distinction of arterialized pseudolesions from hepatocellular carcinoma M.A. 
Stockholm/SE
Purpose: To determine differences between arterial pseudo-lesions (APL) and hepatocellular carcinoma (HCC) of the cirrhotic liver at perfusion computed tomography (P-CT). Material and Methods: 41 APL and 28 HCC in 20 cirrhotic patients with arterio-portal shunting (15 men; mean age 65±10), who underwent 4D-spiral P-CT for evaluation of HCC pre-(n=9) and post-(n=11) transarterial-chemoembolisation (TACE), were retrospectively included in this dual-center study using CT-imaging follow-up as the standard of reference. All lesions were qualitatively analyzed for shape (wedge, irregular, nodular) and location (adjunct or not-adjunct to a fistula) as well as quantitatively analyzed for arterial-liver-perfusion (ALP), portal-venous perfusion (PVP), and hepatic perfusion index (HPI).
Results: APL were mainly wedge-shaped (25/41, 61%) or irregular (15/41, 37%), while HCC were mainly nodular (17/28, 61%) or irregular (11/28, 39%). Before TACE, shape of APL and HCC was significantly different (P<0.001), whereas no difference was seen after TACE (P>0.05). PVP and HPI were significantly different between APL and HCC for both pre-and post-treated lesions (all, P<0.001). APL adjunct to a fistula (n=17) showed a similar HPI as HCC (P=0.142), but PVP of HCC was significantly lower than APL regardless of the distance to a fistula (P>0.05). Conclusion: Arterio-portal shunting should be considered one of the causes of arterialized lesions in the cirrhotic liver, which can mimic HCC. Lesion configuration and PVP allow best for distinction between APS and HCC at P-CT.
SS 12.07
Compartment model analysis of intravenous contrast-enhanced dynamic CT in hepatic hemodynamics: a comparison with intra-arterial contrast-enhanced CT D. Komatsu, A. Yamada, T. Suzuki, M. Kurozumi, Y. Fujinaga, K. Ueda, M. Kadoya; Matsumoto/JP Purpose: To evaluate arterial and portal venous vascularity of the liver independently using compartment model analysis of intravenous contrast-enhanced dynamic CT (IVCED-CT). Material and Methods: Thirty-five consecutive patients with radiologically diagnosed hepatocellular carcinoma (HCC) who underwent both IVCED-CT and intra-arterial contrast-enhanced CT (IACE-CT) were included in this study. Upper abdomen was scanned at pre-contrast and 22, 28, 34, 40, 46, 52, 58, 90, 210 seconds after intravenous administration of contrast media in IVCED-CT. Absolute inflow blood velocity constant of hepatic artery [K 1a ] and portal vein [K 1p ] of the background liver and HCC were quantitatively evaluated by compartment model analysis of IVCED-CT. Arterial and portal venous vascularity levels of HCC against background liver were compared between these hemodynamic parameters, IVCED-CT or IACE-CT findings. Results: According to IACE-CT, all HCCs were hypervascular in arterial blood flow and hypovascular in portal venous blood flow against background liver. The accuracy of evaluating arterial vascularity level was 100% by K 1a and IVCED-CT early phase (22-58 s), respectively. The accuracy of evaluating portal venous vascularity level was 100% by K 1p , 63% (95%CI: 47-79%) by IVCED-CT delayed phase (90-210 s), respectively. Conclusion: The arterial and portal venous vascularity of the liver can be evaluated independently and quantitatively using compartment model analysis of IVCED-CT which can be equivalent to IACE-CT.
SS 12.08
Routine staging CT thorax in treatment-naïve hepatocellular carcinoma prior to loco-regional therapy: is there a need? P.W. Leong, K.S. Lim, U. Pua; Singapore/SG Purpose: Pulmonary metastases (PM), whilst the commonest site of distant metastasis in hepatocellular carcinoma (HCC), remain a rare occurrence. Their presence, nevertheless, contraindicates curative loco-regional therapy. The role of pre-treatment staging CT thorax is currently unclear. This study aims to assess the utility of pre-treatment CT thorax and predictive value of imaging features of HCC for PM. Material and Methods: Retrospective review of continuous cases of treatment-naïve HCC referred for locoregional therapy between 2004 and 2013 was done. Patients with pre-treatment CT thorax were evaluated for presence of PM. HCC features (size, numbers, vascular invasion, nodal status, bone metastases) were recorded. Univarate analysis (Chi-square/Fisher's exact test) and multivariate logistic regression were performed with a statistician for significant association. Results: 780 patients were reviewed, of which 135 patients had staging CT thorax done. PM (n=17, 12.6%), benign (n=41, 30.4%) and indeterminate lung lesions (n=6, 4.4%) were detected. All the patients with PM were eventually declined loco-regional therapy. Univariate analysis showed significant association between PM with number of intra-hepatic lesions (p<0.01), primary tumour size (p=0.018) and presence of vascular invasion (p<0.01). On multivariate analysis, number of intra-hepatic lesions (OR: 9.7; 95% CI: 1.6-57.2, p=0.012) and presence of both hepatic and portal venous invasion (OR: 11.8; 95% CI: 1.1-128.8, p=0.043) are two independent positive predictors of PM.
Conclusion:
The yield of staging CT thorax in treatment-naïve HCC is low and its routine use is not recommended. It can, however, be considered in selected HCC cases with multiple lesions or vascular invasion. Purpose: To assess value of diffusion-weighted imaging (DWI) as prognostic marker in preoperative evaluation of mass-forming intrahepatic cholangiocarcinoma (ICC). Material and Methods: Ninety-one patients who had undergone hepatic resection and DWI between October 2008 and February 2014 for mass-forming ICC were included. Two radiologists evaluated degree of diffusion restriction on DWI with apparent diffusion coefficient (ADC) maps in consensus. Patients were classified into two groups: group 1 included those in whom less than one-third of tumor showed diffusion restriction. Group 2 included those in whom more than one-third of tumor showed diffusion restriction. Two groups were compared with respect to disease-free survival and overall survival. Results: There were 49 patients in group 1 and 42 patients in group 2. The 1-, 2-, and 3-year disease-free survival rates were 28.2%, 13.3%, and 8.9% for group 1, whereas 82.2%, 78.9%, and 78.9% for group 2, respectively. The 1-, 2-, and 3-year overall survival rates were 78.8%, 39.6% and 18.3% for group 1, whereas 92.2%, 83.8%, and 83.8% for group 2, respectively. Disease-free survival rate and overall survival rate for group 1 were significantly lower than those for group 2 (P<.0001). Multivariate analysis revealed that diffusion restriction (P=.002) and intrahepatic metastasis (P=.008) were independent prognostic factors for overall survival. Conclusion: Degree of diffusion restriction on DWI with ADC maps could play a role as prognostic marker in preoperative evaluation of mass-forming ICC. Loughborough/UK Purpose: To determine the effect of variable navigation speed along the colonic centerline during endoluminal CT colonography (CTC) on eye movement behaviour and polyp detection. Material and Methods: Ethical permission was granted for this prospective study. 23 radiologists (18M:5F; age range 30-63) were asked to indicate their normal preferred CTC navigation speed using an adjustable CTC video. They then viewed a selection of CTC videos presented at different, non-adjustable speeds. Videos were repeated at 4 different speeds (min: 1cm/sec; max: 4.5cm/ sec; total=40 videos/participant). Simultaneously, eye positions were logged by a Tobii X60 infra-red eye tracker. Radiologists were also asked to click their mouse when they detected a polyp on the screen ("polyp identifications"). Preferred playback speed was tested again at the end of the viewing period. Results: Average preferred playback speed was 1.18cm/sec and showed no significant difference by gender (p=0.37) or for experienced (>300 cases) colonographers (p=0.73). There was a consistent decrease in the number of polyp identifications/viewing as speed increased, from 1.2 identifications/viewing at the slowest speed to 0.8 identifications/viewing at the fastest. This was true whether or not the video depicted a true-positive polyp. Conclusion: Average preferred navigation speed at CTC is approximately 1.2cm/sec; increasing from this speed leads to lower polyp identification rates.
SS 13.04
Patient factors predictive of decreased endoscopic performance from quantitative CTC: does age and body habitus impact colonic morphology and endoscopic performance? C.N. Princeton, NJ/US Purpose: To assess impact of age and body habitus on colonic morphology using CTC quantification software and correlate with endoscopic performance. Material and Methods: CTC datasets from 32 patients with history of failed optical colonoscopy (OC) were evaluated. Quantitative metrics included colonic/segmental length, tortuosity (number of high curvature points (HCP)), and compactness (boxed volume containing centerline divided by centerline length). Patient factors included age (over/under 65, n=16/16), height (over/ under 5'6", n=14/18) and body mass index (BMI) (over/under 25, n=23/9). Each dataset was quantified twice. The groups were compared with two-tailed Student's t test. Distance navigated at colonoscopy was compared. Results: Older patients had more tortuous colons (p=0.05). Shorter patients had shorter and more compact colons (p≤0.04), with greater tortuosity although not significant (p=0.26). Thinner patients had more compact and tortuous colons (p≤0.02). Although not significant, patient height mostly correlated with distance navigated at colonoscopy, with 67% vs. 47%, 50% vs. 35%, and 33% vs. 17% successfully reaching the transverse segment, hepatic flexure, and ascending segment in taller vs. shorter patients, respectively, despite longer colons in taller patients. Conclusion: Older, shorter, and thinner patients had more tortuous and compact colons, which trended towards poorer endoscopic performance, most notably in shorter patients. This quantitative evidence supports clinical observations regarding more challenging optical colonoscopies in these patient groups. Patient factors such as age and body habitus should be considered when weighing options of CTC versus OC.
SS 13.05
Prognostic value of the diverticular disease severity score based on CTC: follow-up in patients recovering from acute diverticulitis N. 
Madison, WI/US
Purpose: To assess the prognostic value of a diverticular disease severity score (DDSS) based on CT colonography (CTC) after acute diverticulitis. Material and Methods: Of 252 patients who had an acute diverticulitis episode, 47 underwent conventional CT for the acute episode and were treated with medical therapy, and had CTC after 9±7 weeks; 17/47 finally underwent surgery. Disease severity was assessed with a 0-to-4 modified Hinchey CTbased score and a 1-to-4 CTC-based DDSS. A phone survey was performed 27 months later (range 4-52) for patients not surgically treated.
Results: Significant correlation was found between CTC-based DDSS and clinical follow-up (p=0.022) or risk of surgery (p=0.007), not between clinical follow-up and CT-based score, extraluminal gas, C-reactive protein serum level, age, gender, or first versus recurrent acute diverticulitis episode. CTC demonstrated relevant additional findings in 5/47 (11%) patients: 2 acute diverticulitis complications (enterocolic and enterotubal fistulae), 2 colon cancers, and 1 an extracolonic (lung) cancer.
Conclusion:
The CTC-based DDSS showed a prognostic value and correlated with the risk of undergoing surgery and clinically relevant additional findings were found in over 10% of patients. CTC could be the preferred test in patients recovering after acute diverticulitis.
SS 13.06
wihtdrawn by the authors SS 13.07 Results: CTC quality was good in 59/66 patients (89%); in 7 cases we obtain suboptimal distension due to diverticular disease or colonic stenosis. At baseline CECT we found: Hinchey I (n=30, 46%); II (n=22, 33%); III (n=14, 21%); IV (n=0, 0%) stages. CTC findings follow-up allowed to keep conservative treatment in all cases of Hinchey I (100%), in 8/22 cases of Hinchey II (36%) and in 8/14 cases of Hinchey III (57%). Twenty patients not understaged (14/22 Hinchey II, 64%, and 6/14 Hinchey III, 43%) underwent laparoscopic/open surgery. CTC also revealed 4 unknown polyps >6 mm and 28 extracolonic findings, 4 with major clinical relevance that changed treatment strategy. Conclusion: CTC is a safe and accurate method to evaluate severity and staging in short-term follow-up of acute complicated diverticulitis allowing an overview of colonic/extracolonic findings and guiding correct therapeutic planning.
SS 13.08
CT in the assessment of early response to neoadjuvant therapy of colon cancer S. Rafaelsen, C. Dam, V. Lund-Rasmussen, J. Pløen, A. Jakobsen; Vejle/DK Purpose: Neoadjuvant drug therapy is presumed to improve outcome in colon cancer. Using multi-detector computed tomography (MDCT) we aimed to assess the early response of neoadjuvant drug therapy for locally advanced colon cancer. Material and Methods: MDCT with i.v. contrast were acquired from consecutive 67 patients before and after preoperative drug therapy. All patients had at baseline histologically confirmed colon cancer with ctT4 or ctT3 tumour with extramural invasion ≥5mm and without distant metastases or peritoneal nodules. The tumour diameter in 2 different planes, extension of extramural tumour invasion and number and size of enlarged lymph nodes were measured before and after the therapy. Results: Mean tumour length was 7.8 cm (95% CI: 5.3-10.4) at baseline and 4.34 cm (95%, CI: 4.0-4.9) after therapy. Mean extramural tumour invasion was 10.6 mm (95% CI: 9.5-11.8) at baseline and 5.7 mm (95% CI: 4.7-6.7) after therapy. Mean number of enlarged lymph nodes was 4.1 (95% CI: 3.4-4.9) at baseline and 2.1 (95% CI: 1.4-2.7) after therapy. According to the RE-CIST criteria 45% (95% CI: 34-57) of the patients had response and 55% (95% CI: 43-67) had stable disease. No one showed progressive disease. Conclusion: Using MDCT we demonstrate a significant reduction in tumour size, extramural tumour invasion, number and size of enlarged lymph nodes following neoadjuvant therapy for colon cancer. Using the RESIST criteria 45% had a response. Purpose: To determine the diagnostic value of pre-operative computed tomography (CT) in detecting colon carcinomas with invasion beyond the bowel wall and the presence of malignant lymph nodes. Material and Methods: A literature search of Ovid, Embase and Pubmed was performed to identify studies reporting on the accuracy of CT for local staging of colon carcinomas. Data extraction was performed by two observers in consensus. The sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated using a bivariate random effects model and summary receiver operating curves (sROC) were generated. Results: Twenty studies fulfilled all the required inclusion criteria. The pooled sensitivity, specificity, DOR for detection of tumour invasion beyond the bowel wall were 90% (95% CI: 83-95%); 69% (95% CI: 62-75%); 20,6 (CI: 20-41%), respectively. For detection of invasion depth of 5mm beyond the bowel wall these values were 77% (CI: 66-85%); 70% (CI: 53-83%); 7.8 (CI: 4.2-14.2) and nodal involvement; 71% (CI: 58-81%); 66% (CI: 46-83%); 4.8 (CI: 2.5-9.4%). Conclusion: CT is reliable in detecting colon carcinomas with tumour invasion through the bowel wall (T1/T2 versus T3/T4). However, detecting tumour invasion of >5mm from the bowel wall (T1/T3ab and T3cd/T4) tumours and especially nodal involvement remains a challenge for CT.
SS 13.10
Quality control in the multicentre PROSPeCT trial: perfusion CT of primary colorectal cancer D. Prezzi, M. Lewis, V. Goh; London/UK Purpose: To assess the image quality of perfusion CT (PCT) studies across all participating sites in the multicentre PROSPeCT trial. Material and Methods: IRB approval and informed consent were obtained. PCT studies from 9 sites and 5 different scanner models were reviewed centrally for image quality. Image noise was assessed by placing a region of interest (ROI) over the bladder, recording the mean CT number (HU) and standard deviation (SD). Calculation of an equivalent patient diameter enabled correlation between image noise and patient size. The quality of the arterial input function was assessed by analysing the peak iodine enhancement value (HU) and its full width at half maximum (FWHM). Patient positioning, with respect to centering in the scanner's field of view (FOV) was also assessed.
Results:
The bladder was included in 86 of 172 PCT. Mean (SD) noise was 17.8 (3.3) on Siemens scanners and 22.3 (2.0) on GE; it increased when applying a sharper reconstruction kernel. An exponential relationship between noise and equivalent patient diameter was found. Peak arterial enhancement was fairly consistent across scanners (>300HU). Patient centering was accurate in the transverse (x) direction (<30mm from centre) but less so in the anteriorposterior (y) direction. Conclusion: Image noise was similar across all scanner models, except when the scan protocol varied from standard. The arterial input function quality was generally good. More attention should be paid to accurate patient centering. 
SS 14.07
Evaluation of a low iodine concentration contrast media in abdominal multiphasic computed tomography using spectral imaging: a prospective study on 210 patients C. Roy, F. Severac, M. Ohana, A. Labani; Strasbourg/FR Purpose: To demonstrate the non-inferiority of a low iodine concentration CM for abdominal multiphasic CT acquired with spectral imaging in comparison with usual CT obtained with high-concentration CM. Material and Methods: 210 patients (BMI<35, GFR>45) with clinically indicated multiphasic abdominal CT were prospectively randomized into three groups of 70 patients. Examinations were performed on a single-source dualenergy CT (GE Discovery 750HD). Two groups underwent conventional CT with iomeprol 400mgI/ml and iomeprol 350mgI/ml. One group was acquired with Iobitridol 250 mgI/ml using spectral with monochromatic images at 75, 65 and 60 keV. Quantitative analysis consisted of HU+SD in aorta, hepatic parenchyma and portal vein, obtained for arterial and portal phases. Image quality of all phases was independently assessed. Quantitative statistical analysis was performed using the Bayesian method with a 95% credibility interval to assess for non-inferiority. HU thresholds were set at 20% for the arterial and 10% for the portal phase. Radiation doses were recorded. Results: For qualitative evaluation, spectral images revealed an excellent image quality. At 60 KeV, 250 was superior for the venous phase. At 65 KeV, 250 revealed no significant differences between the 350 or 400 concentrations for all sites. At 75 KeV, 250 was inferior for all sites. Increase in radiation doses was less than 10%. Conclusion: Low iodine contrast offers equivalent image quality and enhancement for both phases, when using spectral imaging, allowing up to 37.5% iodine reduction.
SS 14.08
Optimal (2011) (2012) (2013) (2014) . Arterial phases were divided into 1/angiographic (contrast in hepatic artery, not in portal veins), 2/early (mild opacification of portal veins), 3/late (contrast in portal veins, not in hepatic veins), 4/portal (contrast in hepatic veins). For each lesion, signal intensity on arterial phase (SI art ) was visually recorded as intense, moderate or low. Lesionto-liver contrast (LC) and relative-lesion-enhancement (RE) were calculated and compared between the two groups using Mann-Whitney test.
SS 14.09
Focal nodular hyperplasia versus inflammatory adenoma: clues for a confident differential diagnosis during MR imaging with a hepatobiliary (Gd-EOB-DTPA) contrast agent V. Battaglia, L. Turturici, A. Mantarro, D. Cioni, C. Bartolozzi; Pisa/IT Purpose: To identify reliable clues to formulate a confident differential diagnosis between focal nodular hyperplasia (FNH) and inflammatory adenoma (IA) in non-cirrhotic, healthy livers. Material and Methods: Thirty-one nodules (3 males, 14 females) were evaluated at MR imaging. For each lesion, biopsy diagnosis was obtained (21 inflammatory adenomas; 10 focal nodular hyperplasia). Lesions' characteristics such as the presence of intralesional fat component, scar on baseline T2W images, and post-contrastographic enhancement on dynamic and hepatobiliary phases were evaluated by two readers by consensus. Results: Hyperintensity on baseline T2W imaging was detected in 20/21 IAs and in 3/10 FNHs. Lesion scar on baseline T2W imaging was specific for FNH diagnosis. No intracellular fat component was appreciable in FNHs, while it was detected in 11/21 IAs. All IA became hypointense on HB phase, while 8/10 FNH showed as iso-or hyperintense; perilesional halo of enhancement on HB phase was present in 17/21 IA and no FNH. Lesions' uptake on both early arterial and parenchymal arterial phases was not a significant clue for differential diagnosis. Conclusion: Lesions' hyperintensity on baseline T2W imaging associated with lesion central hypointensity and perilesional enhancement halo on HB phase is strongly related to a diagnosis of IA. The presence of intralesional fat does further support the diagnosis of IA.
SS 14.10
Diagnostic management of atypical benign hepatocellular lesions imaged at MR-CEUS vs. hepato-biliary phase imaging L. Tselikas Purpose: To compare the added value of delayed hepatobiliary phase (HBP) imaging using gadolinium (Gd)-BOPTA-enhanced MRI and contrast-enhanced ultrasound (CEUS) in patients with atypical benign hepatocellular lesions (BLT). Material and Methods: Eighty-three BLT-46 focal nodular hyperplasia (FNH) and 37 hepatocellular adenomas (HCA)-with atypical presentation on liver contrast-enhanced MR using extracellular Gd chelates (CE-MRI), in 54 patients were retrospectively included in this IRB-approved study. All patients underwent HBP-MRI and CEUS. Two radiologists independently reviewed 2 sets of images; set-1: CE-MRI and HBP-MRI; set-2: CE-MRI and CEUS. All HCA and 30.4% of all FNH were documented on pathology, the remaining FNH being diagnosed in board decisions and a minimum follow-up of 12 months. Sensitivity (Se) and specificity (Spe) were compared between the two sets, and subgroup analyses according to lesion's size were performed. Results: Regardless of lesion size, the respective Se and Spe of both data sets were not statistically different (95.7 and 100% vs. 78.3 and 94 .6% for set 1 and 2, respectively; p=0.18). For lesions larger than 35mm, although both sets had similar excellent specificity (100%), sensitivity was higher for CE-MRI + HBP-MRI set (100% vs. 40%); p=0.04. Conclusion: Although the overall performances of CE-MRI + HBP-MRI and CE-MRI + CEUS are similar, the use of HBP imaging should be advocated over CEUS in larger than 35mm benign hepatocellular lesions. Shanghai/CN Purpose: One of the important aspects of rectal cancer staging is the measurement of the invasion depth of a tumour into the mesorectal fat in millimetres. This determines whether there is a T3ab (<5mm) or T3cd (>5mm) tumour, which can change treatment. Measurement of this factor can be arbitrary. Aim was to evaluate reproducibility of the measurement of invasion depth into the mesorectal fat by different readers. Material and Methods: Sixty-one patients with a pathologically proven T3 tumour were selected. Two readers with different experience in reading rectal cancer MRI (2 years and 5 years) measured the maximal depth of invasion of tumour into mesorectal fat in the axial plane perpendicular to the tumour axis. Clock position of the measurement was registered. ICC and Bland-Altman plots were used for analyses. Results: Intraclass correlation coefficient was 0.61. The Bland-Altman plot showed a mean difference between measurements of 2.45 (SD 3.53) mm with limits of agreement of -4.45 to 9.39. Differences between measurements ranged from -9 to 15 mm. In 36% of patients, the clock position of the measurements of both readers was not in the same quadrant. Conclusion: Reproducibility of measurement of tumour invasion depth into mesorectal fat is low, both with regard to the depth and to the location of the deepest invasion. Therefore, the distinction between T3ab and T3cd tumours is unreliable and should not be used for treatment decisions. Purpose: To assess the day-to-day reproducibility of loco-regional and global MRI textures features derived from primary rectal cancer. Material and Methods: Following IRB approval and informed consent, 28 MRIs performed on consecutive days as part of a prospective study in 14 patients with rectal cancer were analysed. 30 locoregional (second-order and higher order statistical) and global (first-order statistical and model-based) texture features were extracted for the whole tumour from the T2-W axial images by 2 different readers. Reproducibility was assessed using Bland-Altman statistics and coefficient of variation (wCV%) recorded. Results: Day-to-day reproducibility was best for global first-order statistical (wCV range: 3-25%), global model-based fractal parameters (wCV range: 2-28%) and second-order locoregional parameters (wCV range: 3-27%). Higher order locoregional parameters had poorer reproducibility, e.g. higher order complexity and short-zone emphasis wCV >50%. Conclusion: Assessment of tumour heterogeneity has shown promise in rectal cancer with a focus to date on global features. Day-to-day reproducibility is good for global texture parameters boding well for clinical practice. Purpose: Diffusion-weighted MRI (DWI) is a very sensitive technique to detect nodes. Assessment of a node-negative status after chemoradiaton (CRT) is important, mainly when considering organ-saving treatments in patients with a good tumour response. Aim was to test the hypothesis that the absence of nodes on DWI after CRT is concordant with a ypN0 status. Material and Methods: 91 rectal cancer patients treated with CRT followed by a restaging MRI (1.5T) including DWI (highest b value b1000) were included. Two independent readers counted the number of nodes visible on DWI after CRT. The number of nodes observed on DWI (0 vs. ≥1) was compared with the number of positive nodes at histopathology (yN0 vs. yN+). Results: 72 patients were ypN0 and 19 were ypN+. In 11 patients, no nodes were observed on DWI by both readers, which was concordant with a yN0-status in all 11 (100%) cases. In the other 61 ypN0 patients, a mean number of 4 (range 1-17) nodes were counted. In the 19 ypN+ patients, a mean number of 4 (range 1-7) nodes were observed on DWI. Conclusion: Although the absence of lymph nodes on DWI is not a frequent finding, it is a reliable predictor of a ypN0 status after neoadjuvant CRT in patients with rectal cancer. As such, DWI can be a helpful tool to select node-negative patients after CRT.
SS 15.05
Multiparameteric PET-MR assessment of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: PET, MR, PET-MR and tumor texture analysis U. Metser, K.S. Jhaveri, G. Murphy, J. Halankar, D. Hussey, P. Dufort, E. Kennedy; Toronto, ON/CA Purpose: Pre-operative chemoradiation therapy (CRT) has now become the standard of treatment for locally advanced rectal cancer (LARC). Patients achieving complete pathologic response (pCR) have significantly improved long-term survival. Preoperative detection of pCR may enable a conservative therapeutic approach in some patients (e.g. those at high risk for surgery). The purpose of the current prospective pilot study was to assess multiparametric qualitative and quantitative MR, PET, PET-MR and tumor texture features in predicting complete pathologic response to CRT in patients with LARC. Material and Methods: Eighteen LARC patients underwent staging with FDG-PET and MR-rectum and 15 had post-CRT restaging. Response was assessed qualitatively and quantitatively. SUV (tumor/background), SUV/ADC, and tumor texture parameters derived via machine learning algorithms (MLA) from PET and multiple MR sequences were correlated with histopathology. Results: A third of patients had pCR. Sensitivity, specificity & accuracy of PET, 60, & 80; 90, 20 & 66.7; 90, 80 & 86.7, respectively . Quantitatively, only tumor-muscle (SUV/ADC) ratio improved prediction of pCR. Of all texture features assessed using MLA, only the classifier trained on pretreatment PET was significant (p=0.034; accuracy, 92.8%). Combined PET and MR texture features did not improve performance. Conclusion: Combined PET-MR has improved specificity compared to PET or MR alone. Tumor to muscle SUV/ADC ratios post-therapy and texture features on baseline PET show promise in predicting pCR post-CRT in LARC. Purpose: Extramural venous invasion (EMVI) is one of the poor prognostic factors in rectal cancer. This study is aimed to assess the diagnostic performance of magnetic resonance imaging for EMVI in post-treatment rectal cancer patients (yMR-EMVI) and determine its prognostic significance. Material and Methods: A total of 60 surgically proven rectal cancer patients who had undergone preoperative MRI following neoadjuvant chemoradiation treatment were included in this study. Two radiologists evaluated the yMR-EMVI and checked inter-observer agreement with weighted kappa analysis. The diagnostic performance based on the histopathologic results using receiver operating characteristic curve was also assessed. In addition, correlation of yMR-EMVI and 5-year disease-free survival (DFS)/overall survival (OS) was identified using Kaplan-Meier survival analysis. Results: Mean observation time was 64 months (range, 3 to 84 months). Interobserver agreement for yMR-EMVI revealed good agreement (weighted kappa, 0.732). Area under the curve of yMR-EMVI by consensus reading of two radiologists was 0.795 (sensitivity 46.2%, specificity 97.3%). The 5-year DFS for yMR-EMVI-positive patients was significantly lower than yMR-EMVI-negative patients-46.4% (95% CI: 27.3%-65.5%) versus 65.8% (95% CI: 59.0%-72.6%) (log rank test, P=0.013). Regarding 5-year OS, yMR-EMVI-positive patients showed lower survival than yMR-EMVI-negative patients-66.7% (95% CI: 52.7%-80.8%) versus 73.8% (95% CI: 68.0%-79.7%), but not significant (log rank test, P=0.094). Conclusion: After neoadjuvant chemoradiation in rectal cancer, yMR-EMVI was well correlated with histopathologic results and significantly related with 5-year DFS in prognosis.
SS 15.07
Distal location and larger thickness may predict a more intense peritumoral inflammatory response to neoadjuvant therapy and shorter disease-free survival in moderate/high-risk rectal cancer patients I. Santiago, R. Rocha, R. Theias, A. Gomes, A. Costa, T. Fiuza, V. Nunes; Amadora/PT Purpose: To evaluate MR T2-weighted imaging markers of peritumoral inflammatory response (PIR) after neoadjuvant (NA) therapy in moderate/high-risk rectal cancer patients and to assess their relation to patient outcome. Material and Methods: All rectal cancer patients with preoperative staging pelvic MR who underwent long-course chemoradiotherapy followed by total mesorectal excision, diagnosed at our Institution between 01-01-2004 and 02-17-2014 were included, totalizing 47 patients (64.8±13.2 years, 30 males). Staging MR high-resolution T2-weighted images were retrospectively evaluated by a radiologist with 5 years of experience in pelvic MR. Tumor dimensional, morphological and signal intensity-derived parameters were recorded, as well as key localizing distances. Variables assessed included maximum thickness (MT), and distances to anal verge, recto-sigmoid junction and peritoneal reflection (DPR). The latter was considered positive when the upper limit of the tumor was located below, null when involved and negative when the lower limit of the tumor was located above. Histopathologic variables were analyzed, including PIR, which was graded as weak/moderate/intense; as well as patient outcome. Results: A significant correlation between the degree of PIR and DPR was found (r=0.600; p=0.002). The degree of PIR was positively correlated to MT (r=0.492; p=0.013 ). An inverse correlation was found between PIR and months to distant disease recurrence (r=-0.683, p=0.043). Conclusion: Tumors located in the low rectum and with large maximum thickness may respond with higher PIR to NA therapy. The degree of PIR may be inversely related to disease-free survival in moderate/high-risk rectal cancer patients. Material and Methods: Thirty-seven patients, diagnosed with locally advanced rectal cancer were prospectively enrolled in the study. All patients underwent MRI on a 3 Tesla before, during and after chemoradiotherapy (CRT). All patients underwent total mesorectal excision (TME). MRTRG was evaluated on T2-weighted fast spin echo (FSE) multiplanar imaging. The MRTRG was determined by the fibrosis/tumour ratio and was divided into 4 grades based on the percentage of fibrosis (<25%, <50%, <75%, 100%). Measurements were performed on all axial images including the tumour. MR-TRG evaluated on the second examination (during therapy) was correlated with the pathological finding after surgery, defined as partial response or complete response. Results: A complete pathologic response was observed only in patients (17) with MRTRG 4 (100% fibrosis) with a negative predictive value of 100%. In lower MRTRG groups (1, 2 and 3), a partial response was observed (20 patients). Conclusion: MRTRG 4 is an accurate predictor of complete response after CRT. When a lower MRTRG is observed, the persistence of disease should be suspected. This method, applied during therapy, may reduce the time to surgery.
SS 15.09
The value of diffusion-weighted MR imaging to identify responders after neoadjuvant chemo-radiation therapy in patient with locally advanced rectal cancer E. Quaia, A.G. Gennari, M. Pontello, M.A. Cova; Trieste/IT Purpose: To define the value of diffusion-weighted MR imaging sequences to identify responders in patients with locally advanced rectal carcinoma after neoadjuvant chemo-and radiation therapy (CRT). Material and Methods: Thirty consecutive patients (mean age ± SD: 71 years ± 6,48; range 53-84; M:F=18:12) with locally advanced rectal carcinoma underwent CRT followed by surgery. Each patient underwent MR imaging before and 6 weeks after the completion of CRT. The tumor ADC percent variation was calculated as: (ADC post -ADC pre ) x 100 / ADC pre . The amount of viable tumor versus fibrosis after CRT was assessed according to the Mandard criteria applied to the surgical specimen. Results: Nineteen patients were classified as responders due to partial (n=14) or complete response (n=5), while 11 patients were classified as non-responders due to stable disease (n=9) or disease progression (n=2). Responders can be differentiated from non-responders based on ADC variation (Wilcoxon test; P< 0.05) which represents the best independent predictor of therapeutic outcome. Diffusion-weighted MR imaging sequences showed a sensitivity of 100% (25/25), a specificity of 60% (3/5), a positive predictive value of 92% (23/25) and a negative predictive value of 100% (3/3) in the detection of complete response. Conclusion: Diffusion-weighted MR images can differentiate responders from non-responders to CRT based on ADC variation which represents the best independent predictor of therapeutic outcome.
SS 15.10
3T MR quantitative imaging in rectal cancer staging: variability in reporting among radiologists E. Guidi 
Material and Methods:
Fifty patients with rectal cancer underwent 3T MRI for preoperative staging and all examinations were assessed by two experienced radiologists. The following tumor markers were measured: site, longitudinal extent, maximum thickness, distance between lesion and puborectalis muscle, depth of extramural spread, distance between lesion and mesorectal fascia. Qualitative parameters were also evaluated: overcoming of anterior peritoneal reflection, mesorectal, iliac and obturator lymph node involvement, pelvic organs and levator ani muscles infiltration. Findings were compared and interobserver agreement was calculated for each parameter using the Cohen's kappa statistics. Results: The interobserver agreement was 0.91 for the lesion site, 0.914 for the distance between lesion and puborectalis muscle, 0.791 for the tumour longitudinal extent, 0.758 for the depth of extramural spread, 0.734 for the maximum thickness of the lesion and 0.48 for the distance between lesion and mesorectal fascia. There was also an agreement between the two observers of 100% for the pelvic organs involvement, of 96% for the overcoming of the anterior peritoneal reflection, of 88% for the mesorectal lymph nodes involvement and of 82% for the levator ani muscles infiltration.
Conclusion:
The overall interobserver agreement was good, but the few differences in tumor marker measurement testify the need to improve the reproducibility of reporting by a standardized approach. Bondy/FR Purpose: To evaluate usefulness of a second biopsy when the first one is inconclusive in patients with a liver nodule identified during screening of chronic liver disease. Material and Methods: This study was a part of a study that evaluated accuracy of imaging for the diagnosis of small hepatocellular carcinoma (HCC) in chronic liver diseases. Among the 439 patients included, in 265 cases inconclusive imaging lead to nodule biopsy of 280 lesions. The following histological results were considered as conclusive: HCC, dysplastic or regenerative nodule, other tumor (benign or malign tumors). When results were inconclusive, a second biopsy was suggested, but not obligatory. Results: 265 patients with 280 nodules underwent a first biopsy (80.8% of men, mean nodule size: 18.96 +/-5.66 mm (range: 7-33)). First biopsy was conclusive in 72.5% of cases (203 nodules): 168 HCCs (82.8%), 13 regenerative nodules (6.4%), 12 dysplastic nodules (5.9%), 10 other tumors (4.9%). Among the 77 cases of inconclusive first biopsy, a second biopsy was performed for 20 nodules within the 6 months after the first one that was conclusive in 75% of cases (15/20 nodules): 12 HCCs, 2 dysplastic nodules, 1 other tumor. In 5 (25%) cases no definitive diagnosis could be provided. Conclusion: Diagnostic accuracy of a second biopsy is not decreased compared to the first in our study. Repeating biopsy could be recommended in patients with a first inconclusive biopsy.
SS 16.02
Intravoxel incoherent motion MR imaging for monitoring treatment response of hepatocellular carcinoma after sorafenib treatment: correlation with histologic findings in animal models Y. ) before and 12 days after the treatment. The apparent diffusion coefficient and IVIM parameters were measured in the entire tumor and at the periphery of the tumor, and they were compared with histologic microvessel density (MVD) and tumor necrosis/apoptosis. Results: The control group showed significantly greater tumor volume and MVD than the treatment groups (P <.001). The final perfusion fraction (f) values (control, 0.41±0.06; 5mg-Tx, 0.29± 0.06; 30mg/kg, 0.22±0.09; P<.001) at the tumor periphery for control group were significantly larger than those for treatment groups. The final true diffusion (D) values (control, 0.37±0.09 x10 -3 mm 2 / sec; 5mg-Tx, 0.46±0.09; 30mg/kg, 0.54±0.06; P<.001) at the tumor periphery were significantly larger in the treatment groups than in the control group. MVD had significant positive correlations with the f (r=.584, P=.003), while no parameter showed significant correlation with tumor necrosis/apoptosis. Conclusion: The IVIM-derived perfusion fraction reflects MVD in animal models of HCC, and may be useful in monitoring anti-angiogenic effect of sorafenib in patients with HCCs.
SS 17.06
The value of sarcopenia and body composition parameters as prognostic factors after esophagectomy for cancer D. Tamandl, M. Paireder, R. Asari, S.F. Schoppmann, A. Ba-Ssalamah; Vienna/AT Purpose: Assessment of the predictive value of sarcopenia and other body composition parameters (BCP) on survival in patients undergoing potentially curative resection of esophageal or esophagogastric cancer (EC). Material and Methods: Two hundred patients were selected from our institutional database, which had resection for EC between 2006 and 2013. Besides demographic and tumor-specific parameters, preoperative CT scans were used to assess established markers of sarcopenia and BCP. Cox regression and Kaplan-Meier analysis were used to assess the association with overall survival (OS) after surgery. Results: Two hundred patients (49F/151M) underwent surgery in the observed time period. Median age was 63.9 years . Sarcopenic patients showed impaired survival compared to individuals who were within physiologic range (hazard ratio [HR] 1.87, 95% confidence interval [CI] 1.15-3.03, p=0.011). Furthermore, low skeletal muscle attenuation <40 HU (HR 1.91, 95% CI 1.12-3.28, p=0.019) and increased fat mass index (HR 3.47, 95% CI 1.27-9.50, p=0.016) were associated with impaired outcome. A composite score (CSS) was generated using those 3 variables. In the multivariable analysis including the CSS and the most relevant clinical variables with survival, only CSS, T-stage and surgical resection margin remained as significant predictors of OS. Conclusion: Patients with sarcopenia have impaired long-term outcome after surgery for EC. This information can be easily extracted from any preoperative CT scan and might help to better manage those patients.
SS 17.07
Role of two-phase dynamic MDCT in differential diagnosis of post-inflammatory esophageal strictures (corrosive, peptic) from esophageal cancer S.A. Buryakina, G.G. Karmazanovsky, Q. Yang, D.V. Ruchkin, O.A. Rymar, E.V. Kondratiev, A.V. Vishnevskaia; Moscow/RU Purpose: To investigate quantitative features which allow to differentiate benign esophageal strictures from esophageal cancer. Material and Methods: CT scans of patients with histopathologically confirmed 26 corrosive esophageal strictures, 12 peptic strictures, 31 esophageal cancer in whom a two-phase dynamic MDCT was performed (arterial and venous phases at 10, 35 seconds, the delayed phase at 6-8 minutes after the injection of contrast media) were reviewed for quantitative features: regions-of-interest measurement of the zone of stenosis and normal esophageal wall and the difference between them. The phase which showed the highest attenuation in the stenosis and stenosis-to-normal esophageal wall attenuation differences (mean ΔCT) was determined. A paired t-test was used to determine which phase showed the highest tumor attenuation and tumor-to-normal esophageal wall attenuation differences. Results: The greatest attenuation of esophageal tumor was in the arterial phase (105 HU), and the mean ΔCT in arterial phase was 23,86±19,31 HU. The greatest attenuation of post-inflammatory strictures was in the delayed phase (104 HU), and the mean ΔCT in delayed phase was 34,03±15,94 HU (P<.01). Conclusion: Although barium studies and endoscopy are more sensitive modalities for detecting benign esophageal stenosis, an additional assessment of the dynamics of contrast material accumulation by benign esophageal strictures using a two-phase dynamic contrast material-enhanced MDCT revealed that arterial and delayed phases are optimal for differentiation of benign esophageal strictures from cancer. 
